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ABSTRACT OF THE DISSERTATION
THE RELATIONSHIP OF A NOVEL MARKER OF INFLAMMATION
(NEUTROPHIL-TO-LYMPHOCYTE RATIO) TO NUTRITIONAL STATUS, DIET
AND CLINICAL OUTCOMES IN HEMODIALYSIS PATIENTS
by
Janet Diaz Martinez
Florida International University, 2019
Miami, Florida
Professor Adriana Campa, Major Professor
The aim of this dissertation was to examine prospectively the relationship of a
novel marker of inflammation (neutrophil-to-lymphocyte ratio) with nutrition markers,
diet and clinical outcomes in a cohort study that included 77 patients from one
hemodialysis (HD) center located in South Florida. Demographics and clinical
parameters were obtained from patients’ medical charts. Nutritional status was
determined at baseline, six and 12 months using the Malnutrition Inflammation Score
(MIS) and the 7-point Subjective Global Assessment (SGA) scale consisting of two
categories: medical history and physical examination. Dietary assessments were
performed, and 24-hour diet recalls were collected at each assessment visit.
Neutrophil-to-Lymphocyte Ratio (NLR) at baseline was associated with
nutritional markers (albumin and body mass index) and was a predictor of
hospitalizations only for diabetics (HR=0.27, 95% CI 0.07-0.96, P=0.044). Participants
with moderate-to-severe malnutrition based on SGA had a 2.67 higher risk for
hospitalization events. MIS >5 was associated with hospitalization (HR=2.11, 95%
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CI:1.12-3.97, P=0.019) and with mortality (HR=13.87, 95% CI:1.56-123.045, P= 0.018)
even after adjustments.
Meeting energy recommendations reduced the chances of hospitalization by 59%
(HR=0.41 95% CI:0.21-0.79, P=0.008), and mortality was reduced by 81% (HR=0.19,
95% CI:0.03-0.98, P=0.049). The intake of two or more fruit servings per day was
associated with lowering mortality risk by 75% (HR=0.246, 95%CI: 0.069- 0.880,
P=0.031); and intake of at least 7 grams of cereal fiber per day lowered mortality risk by
81% (HR= 0.187; 95.0% CI:0.05-0.693, P=0.012).
Our findings support the use of NLR, an inexpensive and convenient
inflammation marker, as strong predictor of outcomes in hemodialysis patients, and
provide preliminary data on the protective effect that a low NLR might have on the risk
of hospitalizations in HD patients. Our study also provided observational evidence for
nutrition interventions that aim at improving nutrition-inflammation status and promoting
adequate energy, protein and fiber intakes in patients living with hemodialysis.
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THE RELATIONSHIP OF A NOVEL MARKER OF INFLAMMATION
(NEUTROPHIL-TO-LYMPHOCYTE RATIO) TO NUTRITIONAL STATUS, DIET
AND CLINICAL OUTCOMES IN HEMODIALYSIS PATIENTS
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CHAPTER I: INTRODUCTION
Statement of Problem
The United States Renal Data System (USRDS) reported in its 2018 Annual Data
Report that in 2016 there were more than 720,000 patients afflicted by end stage renal
disease (ESRD) in the country and the number of prevalent cases rises by about 20,000
per year.1 Over two-thirds of patients with ESRD who are receiving dialysis have been
hospitalized annually, experiencing an average of nearly two hospital admissions and a
20-25% mortality rate per year,1 and a 5-year survival rate of 35%. For these patients,
cardiovascular and infective diseases account for approximately 50% and 20% of deaths
respectively.1
Malnutrition also bestows a considerable socioeconomic challenge in today’s U.S.
hemodialysis healthcare settings, with an estimated prevalence from approximately 20%
to over 90%, depending on the assessment tool been used.2 Large epidemiological studies
have evidently demonstrated a significant relationship between malnutrition and
mortality in patients with renal failure.3-5 For example, the Netherlands Cooperative
Study on Chronic Kidney Disease4 and the Dialysis Outcome and Practice Study
(DOPPS)5 both revealed that malnourished patients had higher mortality risk when
compared to those who had adequate nutrition status.4,5 Furthermore, nutrition parameters
from anthropometrics, biochemical measurements, and daily dietary intake can strongly
predict mortality.6,7
Patients receiving hemodialysis suffer from lack of appetite and energy,
gastrointestinal impairment, fatigue, nutrient imbalances, emotional stress and other
multiple comorbidities, which all can lead to malnutrition.7,8 These factors, however,

2

cannot completely explain the signs of malnutrition seen in this population, and
additional mechanisms have been studied to better understand the etiology of this
phenomenon, including nutrient deficiencies, diet patterns and inflammation.8-10,14.
The impact of inflammation, as a risk factor for malnutrition, has been recently
recognized.11 Multiple markers of inflammation have been shown to be strongly
associated with adverse clinical outcomes and nutrition parameters in the hemodialysis
population.12-14 Therefore, chronic inflammation may be a crucial factor that causally
links malnutrition to increased morbidity and mortality among dialysis
patients.14Although there are many studies that have investigated specific nutrient intakes
of hemodialysis patients,15-17 there is limited information evaluating overall diet quality
using diet quality indices and correlating them with outcomes in hemodialysis patients,
including inflammation. This potential relationship warrants further investigation, as the
acting mechanisms are not clearly delineated.
This study proposes to examine major contributors to adequate nutritional status
in hemodialysis patients by examining their dietary quantitative and qualitative intake
and the relationships with a novel marker of inflammation and with dialysis outcomes. If
a relationship is uncovered, it will provide new tools for medical professionals to
alleviate and prevent the damage that chronic inflammation inflicts on these patients, and
that may be linked to malnutrition, mortality and hospitalizations. To the best of our
knowledge, this is the first prospective study to examine the association between a novel
biomarker of inflammation (NLR) with diet quality, diet quantity and dialysis outcomes
in patients receiving maintenance hemodialysis.
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Moreover, promoting and facilitating healthy diet patterns that increase the
overall nutritional quality of the diet could be an effective intervention to reduce
hospitalizations and mortality and improve the well- being of people living with ESRD.

Significance of Study
Currently, over 400,000 patients are receiving hemodialysis in the United States
and Medicare has been spending nearly $90,000 per patient per year.1 The ultimate goal
of receiving hemodialysis is to reverse the uremia associated with CKD stage 5, while
minimizing complications and improving length and quality of life for these patients.
Unfortunately, two-thirds of hemodialysis patients are hospitalized annually,
experiencing an average of nearly two hospital admissions per year,1 which represents a
significant financial burden for society and accounts for approximately 40% of total
Medicare expenditures for dialysis patients.1 Compared to the general population, the
mortality rate of these patients continues to be very high.1 Although malnutrition and proinflammatory states are very common among ESRD patients and are considered risk
factors for mortality, they cannot totally explain the high rates of mortality and
hospitalization of hemodialysis patients. The relationship between nutrition-inflammation
status and hemodialysis patient’s diet (quantity and quality) and their associations with
mortality and hospitalization are not fully understood. If a relationship is indicated, it will
provide new tools for medical professionals to identify, alleviate and prevent the damage
that chronic inflammation inflicts on these patients, and that may be linked to adverse
dialysis outcomes.
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The evidence from the literature generates to the following questions:
•

Does the neutrophil-to lymphocyte ratio (NLR), as a marker of inflammation, has
a prognostic value for hospitalization and mortality in hemodialysis patients?
What are the NLR ‘s threshold levels that optimally distinguish non-inflamed
versus inflamed patients?

•

Which available assessment tool for HD patients, the Subjective Global
Assessment (SGA) or the Malnutrition-Inflammation Score (MIS), is a more
marker to detect protein energy wasting (PEW), and more strongly associated
with dietary intake and dialysis outcomes?

•

Are diet quality indices associated with the number of hospitalizations and deaths
in this population?

•

Is there a relationship between the components of the diet, NLR as a marker of
inflammation and dialysis outcomes?

This study’s aims were to examining major contributors to adequate nutritional status
in hemodialysis patients by examining their inflammation status using a novel marker of
inflammation NLR, an index of diet quality (AHEI) and quantity (food records),
malnutrition scores (SGA and MIS) and the relationship of these markers with clinical
outcomes (hospitalization events and mortality).
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Innovation
To the best of our knowledge, this is the first prospective study to examine the
association of inflammation status, measured by NLR a novel marker of inflammation,
with nutritional status, quality and quantity of dietary intake, hospitalization and
mortality in patients receiving hemodialysis. A new immunological-based marker, NLR,
constructed from accessible and inexpensive blood counts used for cancer patients and
other conditions, is used for the first time in a cohort of hemodialysis participants to test
its relationship with diet and nutrition status and its potential as a predictor of
hospitalization and mortality.

Specific Aims and Hypothesis
CHAPTER III: ASSOCIATION BETWEEN NEUTROPHIL-TO-LYMPHOCYTE
RATIO, NUTRITION PARAMETERS AND HEALTH OUTCOMES IN
HEMODIALYSIS PATIENTS
Specific Aim 1: To investigate the relationship of inflammation with measures of
nutritional status and health outcomes in patients undergoing hemodialysis over a oneyear period.
Hypothesis 1a: In patients undergoing hemodialysis, the presence of proinflammatory status (increased neutrophil-to-lymphocyte ratio) is
associated with higher number of hospitalizations and deaths over a oneyear period.
Hypothesis 1b: In patients undergoing hemodialysis, the presence of proinflammatory status (increased neutrophil-to-lymphocyte ratio) is
associated with poorer measures of nutritional status indicated by BMI,
albumin, net protein catabolic rate, cross-sectionally and over a one-year
period.

6

CHAPTER IV: NUTRITIONAL STATUS AND DIETARY INTAKE AS
PREDICTORS OF POOR OUTCOMES IN HEMODIALYSIS PATIENTS
Specific Aim 2: To assess the nutritional status by the Subjective Global Assessment
(SGA) and malnutrition-inflammation score (MIS), dietary intake and to examine the
relationship of these variables with health outcomes in patients undergoing hemodialysis
over a one-year period.
Hypothesis 2a: In patients undergoing hemodialysis, the presence of
malnutrition determined by MIS and SGA scores are associated with
higher number of hospitalizations and deaths over a one-year period.
Hypothesis 2b: In patients undergoing hemodialysis, those meeting the
renal dietary guidelines for protein and energy intake have lower number
of hospitalizations and deaths over a one-year period compared with those
who are not meeting renal dietary guidelines.
CHAPTER V: DIET QUALITY AS PREDICTOR OF POOR OUTCOMES IN
HEMODIALYSIS PATIENTS AND ITS RELATIONSHIP TO INFLAMMATION
Specific Aim 3: To investigate the relationship of diet quality (AHEI) with inflammation
and health outcomes in patients undergoing hemodialysis over a one-year period.
Hypothesis 3a: In patients undergoing hemodialysis, higher AHEI score
are associated with lower number of hospitalizations and deaths over a
one-year period when compared with those with lower AHEI score.
Hypothesis 3b: In patients undergoing hemodialysis, those with higher
AHEI score will be have lower inflammation (lower neutrophil–
lymphocyte ratio) when compared with those with lower AHEI score.
Sample Size
The study recruited a convenience sample of 77 participants from one single
dialysis units of DaVita Kidney Care in the State of Florida. DaVita International serves
10 countries, including the United States and approximately 1.7 million patients.18
Statistical Analyses
Table 1 describes the dependent and independent variables tested in each chapter
for each hypothesis and the statistical analyses used for each of the hypotheses.
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Table 1: Statistical Analysis of the Hypotheses
Hypotheses

Dependent Variable

Mortality:
Dichotomous
variables Y/N
Chapter III
Hypothesis
1a

Hospitalization:
Dichotomous
variables Y/N
*Obtained from
Medical chart

Chapter III
Hypothesis
1b

Chapter IV
Hypothesis
2a

NLR and NLR
quartiles
Continuous and
ordinal variable
*Obtained from
Neutrophil% and
Lymphocyte % in
blood

Mortality:
Dichotomous
variables Y/N

Independent Variable

NLR and NLR
quartiles
Continuous and
ordinal variable
*Obtained from
Neutrophil% and
Lymphocyte % in
blood

BMI
Continuous variable
measured as weight in
kg/ height in meters
squared
Albumin
Continuous variable
nPCR
Continuous variable
TIBC
Continuous variable
*The three values
obtained from blood
SGA, MIS
Dichotomous
variables:
0-wellnourished
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Statistical Analysis
Multivariate and
stepwise cox regression
analysis to identify
outcome’s predictors.
Proportional Hazard
Survival Models were
performed to compare
hazard ratios on time to
event (death and
hospitalizations for
NLR. Survival and
hospitalization curves
for NLR were estimated
by Kaplan-Meier
analysis. One-way
Anova, student’s t tests,
chi-square tests, or
Mann-Whitney tests
were used to compare
variables between
hospitalized and not
hospitalized; survivors
and non-survivors, and
inflammation quartiles,
as appropriate.
Pearson and Spearman
correlations, as deemed
appropriate were
performed to evaluate
the relationship between
NLR and BMI,
Albumin, nPCR and
TIBC.

Proportional Hazard
Survival Models were
performed to compare
hazard ratios on time to

Hospitalization:
Dichotomous
variables Y/N

1-malnourished
*From nutrition
assessment by RD

*Obtained from
Medical chart

Mortality:
Dichotomous
variables Y/N
Chapter IV
Hypothesis
2b

Hospitalization:
Dichotomous
variables Y/N
*Obtained from
Medical chart

Mortality:
Dichotomous
variables Y/N
Chapter V
Hypothesis
3a

Hospitalization:
Dichotomous
variables Y/N
*Obtained from
Medical chart

Energy and protein
intake
Dichotomous
variables:
0-did not meet
recommendations
1-meet
recommendations
*Obtained from 24hour recall by RD

AHEI
Continuous and
ordinal variable.
Quartiles compare
low quartile vs high
quartile
*Calculated index
based on 24-hour
recall by RD
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event death and
hospitalizations for SGA
and MIS. Survival and
hospitalization curves
for MIS and SGA were
estimated by KaplanMeier analysis.
Student’s t tests, chisquare tests, or MannWhitney tests were used
to compare variables
between malnourished
and well-nourished as
appropriate,
Proportional Hazard
Survival Models were
performed to compare
hazard ratios on time to
event (death and
hospitalizations for Met
recommendations or not
Student’s t tests, chisquare tests, or MannWhitney tests were used
to compare variables
between patients that
meet nutrition
recommendations and
not, Survival and
hospitalization curves
for energy
recommendations were
estimated by KaplanMeier analysis
Proportional Hazard
Survival Models were
performed to compare
hazard ratios on time to
event (death and
hospitalizations. Oneway ANOVA, student’s
t tests, chi-square tests,
or Mann-Whitney tests
were used to compare
variables between low

quartile versus high
quartile of AHEI as
appropriate.

Chapter V
Hypothesis
3b

NLR and NLR
quartiles
Continuous and
ordinal variable
*Obtained from
Neutrophil% and
Lymphocyte % in
blood

AHEI
Continuous and
ordinal variable.
Quartiles compare
low quartile vs high
quartile
*Calculated index
based on 24-hour
recall by RD

*Sources of variables
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Proportional Hazard
Models were performed
to compare hazard ratio.
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CHAPTER II: LITERATURE REVIEW

Chronic and End-Stage Renal Disease
In 2002, the National Kidney Foundation (NKF), through the Kidney Disease
Outcomes Quality Initiative (KDOQI) defined the most salient characteristics of chronic
and end-stage renal disease.1 Later in 2004, the International Kidney Disease Improving
Global Outcomes adopted these guidelines that defined a variety of disorders categorized
by alterations in both kidney structure and function, with diverse causes and disease
stages.2 Many risk factors have been recognized for renal failure, which includes genetic,
socio-demographic and underlying conditions that may initiate and progress kidney
disease.3
End-stage renal disease (ESRD) refers to a condition of chronic kidney failure
that is treated by replacement renal therapy (RRT), mostly chronic dialysis or
transplantation.1,2 The United States Renal Data System (USRDS) estimated in the 2018
Annual Data Report4 that approximately 726, 331 patients are identified with ESRD
annually with an estimated 5% increase per year.4 Dialysis, in its two chronic modalities,
hemodialysis and peritoneal dialysis, are life-saving and costly therapies for patients with
ESRD. In the United States over 450,000 people are currently receiving hemodialysis,
costing Medicare approximately $90,000 per person annually in 2012,5 part of this heavy
economic burden comes from the high prevalence of hospitalization that affect this
population.3,5
Chronic Dialysis prevents death from uremia of patients with ESRD and even
though during the past decade, an uptrend has been observed toward an earlier initiation
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of RRT, patient survival remains a critical matter.6 Mortality rates for dialysis patients are
seven times higher than the rates of people with similar age in the general population.7
Once hemodialysis starts, the expected remaining lifespan was approximately eight years
in the 2018 USRDS report,7 with an approximate mortality rates between 20% and 25%
and a 35-40% five-year survival rate, including differences on race and age.8
There are several prevalent causes of mortality in dialysis patients, but the most
frequent causes of death among ESRD patients are cardiovascular disease (~50%
mortality), infections, which are related frequently to the HD vascular access (~20%
mortality), and removal from dialysis which accounts from 15% to 25 % of deaths.8

Nutritional status of patients living with CKD and ESRD
Dialysis, as a form of renal replacement therapy, has been implemented for almost
60 years in United States, and the number is currently approaching half-a-million patients
living with dialysis.4 Despite major advances in protocols, dialysis technology, medical
and pharmaceutical interventions, hemodialysis patients suffer from a high prevalence of
several nutrition imbalances and malnutrition.9,10,13
The estimation of the Glomerular filtration Rate (GFR) is a marker of kidney
function and an indicator of stage of kidney disease. It is calculated by measuring the rate
of the blood-flow through the kidneys.1 As GFR decreases, kidney disease progresses to
advanced stages. Parallel to this renal function’s decline, patients start facing nutritional
challenges represented by a number of nutrient imbalances and altered nutrition-related
markers.9,11,13 The Third United States NHANES found that a decrease in GFR under 30
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mL/min/1.73 m2 had an independent association with malnutrition among participants
60-year-old and older.11

Assessment of nutritional status in HD patients
Kidney disease progression and its chronic therapy may lead to a variety of
metabolic and nutritional alterations.9,13A recent publication, which discussed from
historical perspective the evolution of the nutritional assessment tools in patients
receiving HD, from basic anthropometrics measurements to more sophisticated nutrition
scores, highlighted the usefulness of a great deal of nutritional tools in assessing the
nutritional status of HD patients.9
Many different tools and parameters are utilized to assess, treat and monitor the
characteristics of malnutrition.12 Several biomarkers and multiple risk-factors have been
used to elucidate the reasons behind the excessive mortality, infections and
cardiovascular events prevalent among ESRD patients.13 Specifically in hemodialysis
patients, several nutrition indicators and indexes are used to attain patient’s nutritional
status, including anthropometrics (BMI, skinfold thickness, waist circumference),
biochemical markers (albumin, net protein catabolic rate, transferrin, lymphocyte count)
and composite nutritional indexes such Subjective Global Assessment (SGA), Geriatric
Nutritional Risk Index (GNRI) and Malnutrition Inflammation Score (MIS) among
others.9,12,13 Most of the studies that have examined the nutritional status of patients living
with dialysis, regardless of the assessment tool used, report some degree of malnutrition
and its relation to adverse disease outcomes.9
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Unfortunately, the current reported global prevalence of protein-energy wasting
(PEW) in CKD patients varies widely, from 10% to 90%.10 In a recent meta-analysis of
contemporary observational studies published in November 2018 on behalf the
International Society of Renal Nutrition and Metabolism (ISRNM), the reasons identified
for this wide margin of prevalence were (1) the great variety of tools utilized in the
different studies to assess nutritional status, (2) the differences in the criteria to diagnose
malnutrition, and (3) the environmental circumstances surrounding the patient. This
meta-analysis advocated for increased medical attention and resources allocation for
PEW evaluation and treatment.10
Frequent and timely nutrition assessment constitutes an essential part of the
routine care of maintenance dialysis patients, and it has paramount importance as it
allows early recognition and treatment of malnutrition.9-13 Nutrition status and diet are of
such consequences, that the United States government has mandated that every dialysis
patient should be assigned a renal dietitian.14
The malnutrition that afflicts patients with renal disease has been described as a
syndrome of adverse changes in nutrition rather than a single condition.15 This syndrome
shares many etiologic factors with those seen in the cachexia syndrome experienced by
non-CKD populations; including the presence of multiple underlying comorbid
conditions, decreased physical activity, deterioration of functional status, decreased
appetite, frailty, and aging.15 Making things more complicated, patients living with
dialysis have increased metabolic demands for protein and energy, which are mobilized
by the catabolic-inducing dialysis treatment itself.15,16 A constellation of metabolic
alterations, including metabolic acidosis, increased resting energy expenditure (REE),
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multiple gastrointestinal and endocrine disorders and the well-known dialysis-associated
inflammatory response, all together, add to these increased requirements for protein and
enery.15,16 It has been recommended that all patients with a history of decreased protein
and energy intake and/or with a sustained decrease in body reserves manifested as
decrease in BMI, albumin, net protein catabolic rate (nPCR), among other markers,
should be carefully assessed for malnutrition.13,15,16 In 2008, Fouque et al.,15
recommended to call protein-energy wasting (PEW) to the syndrome that describes loss
of body protein mass and reserves of energy in patients with CKD and ESRD, in
addition, the authors proposed a diagnosis criteria. Later in 2013, ISRNM provided a
consensus statement16 with the multiple purpose of (1) raising more awareness around
the high prevalence of malnutrition, (2) alleviate terminology confusion and (3) better
identify research needs that, ultimately, could provide a better understanding of this
syndrome.16 In this consensus statement, it is highlighted that insufficient dietary intake,
diminished appetite, and multiple dietary restrictions imposed upon renal patients were
not the only contributors to PEW syndrome.16 It was proposed that other highly prevalent
factors among patients with kidney disease were also involved in the PEW development.
This statement denotes the multifactorial and complex nature of the PEW syndrome.
Hence, regardless of the tool being used to attain the nutrition assessment of renal
patients, it is critically important that these evaluations are clinically meaningful. The
assessment tool should be sensitive enough to identify, stratify and classify patients based
on presence, degree and/or risk to develop PEW. In accordance with the standard of care
for the development of the Nutrition Care Process of these patients,12 the ultimate goal of

17

any nutrition assessment is to design a nutrition intervention to alleviate PEW’s sign and
symptoms.10, 12,13, 15,16

The impact of inadequate nutritional status of patients with renal disease on
morbidity and mortality.
Malnutrition presents a considerable socioeconomic challenge in today’s U.S.
hemodialysis healthcare setting.4-9 Nutritional status parameters are consistently found to
be the strongest predictors of morbidity and mortality in this population.17-23 Small and
large observational studies conducted in patients with different stages of renal failure
have provided sound epidemiological evidence about the significant relationship between
malnutrition and mortality.17-21 For example, Acchiardo and colleagues,17 examined the
nutritional status of 120 patients receiving hemodialysis by indirectly measuring dietary
protein intake. This small, but remarkable study, reported that malnutrition was a crucial
predicting factor that influences morbidity and mortality. The authors suggested that
patients who have abnormal measurements of nutritional status must be stratified as
patients at high nutritional risk, and be treated aggressively, according to their degree of
malnutrition. In another study with larger study sample size, Dwyer et al,18 examined the
association of nutrition markers measured prior to randomization to the well-known
HEMO study with mortality.19 The nutrition markers included by the authors were
biochemical markers, anthropometric and direct dietary indicators that were collected
routinely. Biochemical indicators included serum albumin, nPCR, serum creatine, and
cholesterol. Anthropometric indicators included post-dialysis weight, BMI, calf
circumference, middle arm circumference and skinfolds.18 The authors obtained
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measurements of dietary energy and protein intake from 24-hour diet recalls collected in
two different days. The study showed that abnormal nutrition indicators, including
anthropometrics, biochemical and dietary intake, increased the relative risk for mortality.
The association between nutrition indicators and outcomes was found to be timedependent with greater effects within 6 months.18 In another highly cited large
prospective epidemiological analysis, Pifer et al.20 included 7719 adult patients on
hemodialysis from United States who were enrolled in the international Dialysis
Outcomes and Practice Patterns Study (DOPPS), which is a study designed to evaluate
dialysis practice patterns in random samples of patients across different countries. The
authors examined the changes in commonly used nutritional parameters such as BMI,
albumin, serum creatinine, and lymphocyte count, and the SGA score. This report
examined the relationship of these nutritional parameters with mortality and found that
low levels of albumin and creatinine at baseline were independently associated with
higher risk for mortality. This remarkable study is cited very often as a reference by the
renal research community, since it was the one that first proposed SGA as a clinical
meaningful tool to attain the nutritional status of this population. Those patients with
lower SGA scores exhibited a higher mortality risk. In agreement with the findings of the
DOPPS, the authors highlighted the usefulness of employing several measurements of
nutritional indicators to predict mortality among hemodialysis patients.
The usefulness of SGA as a predictor of mortality was confirmed by another
frequently referenced study, The Netherlands Cooperative Study on the Adequacy of
Dialysis-2 Study Group. De Mutsert et al.21 clearly demonstrated, through a longitudinal
multicenter analysis that included over 1600 chronic dialysis patients, that malnutrition,
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measured at baseline by SGA, increased mortality risk by two-fold in seven years of
follow-up. This study also demonstrated that the association between malnutrition and
mortality is time-dependent. Interestingly, the association became stronger after
adjustments by pre-determined covariates.21
Other authors have examined the association of malnutrition and dialysis
outcomes, including inflammation, hospitalization and mortality, by using different
composite nutrition scores, which share some similarities with SGA. Kalantar and
colleageues22 designed a composite score named the Malnutrition Inflammation Score
(MIS), which is a modified version of SGA. This composite score, specifically designed
and validated for its use in maintenance hemodialysis (HD) patients, showed significant
correlations with common measurements of inflammation, nutrition and anemia. Patients
with higher MIS score, as an indicator of the presence of malnutrition-inflammation
status, had greater rate of hospitalization and mortality. The author concluded that MIS
was a strong predictor for adverse outcomes in HD patients.22
In a different prospective analysis of the outcomes from the DOPPS, which
encompassed data from 1996 to 2008, Lopes et al.23 included random samples of
maintenance hemodialysis (MHD) patients from the United States, seven European
countries, Canada, Australia, New Zealand, and Japan. The authors investigated the
individual effect of nutrition indicators and their joint effect on mortality rate in a cohort
of 40,950 MHD patients. The authors examined the individual and joint effects of a
battery of biochemical and anthropometric measurements, including creatinine, albumin,
nPCR, and BMI, on mortality risk. They also reported that nutritional indicators
significantly differed by country and by patient characteristics and exhibited high degree
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of variabilities. An impoverished nutritional status indicated by each nutrition parameter
was independently associated with an increased mortality risk across the different
regions. Interestingly, the specific correlation between low albumin and high mortality
risk was found to be stronger for patients with lower body mass, as indicated by lower
BMI and/or lower serum creatinine.23 These revealing facts clearly illustrated the
multifactorial and complex characteristics of the malnutrition seen in this population,
which was previously proposed.13,15 Therefore, the conclusions from this study confirmed
the usefulness and the need of utilizing multiple tools to assess and monitor the
nutritional status of patients receiving hemodialysis.20,23
Similarly, results that emerged from studies conducted in patients receiving
another dialysis treatment modality, continuous ambulatory peritoneal dialysis (CAPD),
have also shown a strong relationship between malnutrition and morbidity and mortality.
For example, Harvinder et al.24 compared protein-energy malnutrition (PEM) prevalence
and the risk for developing it between patients receiving hemodialysis (HD) and CAPD.
The authors compared a total of 155 HD versus 90 CAPD. For assessing PEM, another
composite nutrition score was used that was specifically designed for dialysis patients
and was called Dialysis Malnutrition Score (DMS). The study compared individual
nutrition parameters (albumin and BMI), DMS and indirect measurements of dietary
intake, and concluded that PEM was more prevalent in patients receiving PD compared to
those receiving HD, as 97% of patients on PD had an albumin lower than 40 g/L
compared with 81% in the group of patients on HD. Low dietary protein intake < 1.2
g/kg/day was also more prevalent among PD patients with a 79% compared with 67% in
HD modality. In contrast, when comparing the prevalence of PEM by using the criteria
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established by DMS in addition to a low dietary energy intake (cut-off value < 30
kcal/kg/day), the investigators did not detect statistically significant differences between
the two treatment modalities. In both group of patients, PD and HD, the prevalence of
PEM was greater than 70% and all patients had equally high risk for developing PEW.
Based on their findings that dietary intake was independently associated with the risk of
PEM for patients in both dialysis modalities (HD and PD), the authors emphasized the
crucial role of periodic nutritional assessments and the paramount importance of
conducting ongoing education and dietary counseling as an effective way to prevent
PEM.24
The association between nutritional indicators and the risk for hospitalization has
also been broadly examined. In Southern Brazil, Szuck and colleagues25 studied the
association between nutrition parameters and hospitalization risk among 138 patients
receiving hemodialysis at a local hospital. The authors found that patients that had at least
one hospital admission during the study-period had higher BMI and lower albumin levels
compared to those who were not hospitalized. The author did not find statistically
significant differences in the nutritional status based on SGA of patients who were
hospitalized compared with those who were not. In this single center cohort study,
albumin was the only significant predictor for hospitalization. Patients with an albumin
level lower than 3.8 g/dL exhibited 2.47 greater incidence of hospitalization (P=0.003). In
agreement with findings from Lopes et al.23 that low BMI jointly with low albumin were
predictors of mortality, this study25 suggested that higher BMI had a protective effect
against death, but, in contrast, that patients who were hospitalized had a significantly
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higher BMI. The controversies about the effect of low or high BMI on adverse outcomes
are still under discussion by the renal research community.10
More recently, in 2018, Kang and colleagues26 conducted a retrospective
observational study, which comprised a total of 144 HD patients, to investigate the
relationship between mortality and nutritional parameters. A composite score (MIS) and a
direct dietary assessment were included in this study. BMI, albumin, nPCR, protein and
energy intakes and MIS were measured at baseline. Survivors had a significanlyt (P=
0.048) higher nPCR level compared to non-survivors. The average energy (26.7 ± 5.8
kcal/kg) and protein intake (0.91 ± 0.21 g/kg) were significantly higher among patients
who survived compared to patients who died (energy=24.3 ± 4.2 kcal/kg and protein
intake=0.82 ± 0.24 g/kg, P<0.05). The MIS was significantly lower among survivors
versus non-survivors (5.2 ± 2.3 vs. 6.1 ± 2.1, P=0.039). In this study, the authors
concluded that a higher MIS and lower energy intake were strong and independent
predictors of mortality. These results added to the previous body of knowledge that
highlights the usefulness of nutrition composite scores, specifically those designed for
dialysis patients, for the detection of the PEW syndrome and their strong power for
predicting adverse outcomes and signaling appropriate early interventions in this
population.10, 22, 26
Mounting evidence is systematically emerging in the field of renal nutrition
research that acknowledges and demonstrates the strong relationship between
malnutrition and disease outcomes, including inflammation, comorbidities and mortality.
Multiple biomarkers and score measurements of nutritional status are linked to the
adverse outcomes seen in HD patients.22, 26, 28,29 Conversely, measures of good nutritional
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status are associated with increased survival, and the degree of recovery of the nutritional
status after nutrition interventions has been found to be inversely related to the number of
re-hospitalizations of HD patients.27 Moreover, nutrition recommendations are in place in
order to prevent PEW from occurring, but no evidence- based consensus has yet been
reached concerning which is the most sensible assessment tool, cut-off points, or the best
management of the nutritional status of patients living with dialysis.10,28,40,66

Inflammation in CKD and ESRD
Lack of appetite, anorexia, decreased intake, and lean body mass losses are
common contributing factors to PEW; however, they cannot explain completely the
malnutrition and wasting syndrome seen in CKD patients.28,29 The excessive mortality in
ESRD has been attributed, in part, to its pro-inflammatory state, characterized by increase
in circulating pro-inflammatory cytokines, leading to leukocyte adhesion, and infiltration
of the vascular endothelium.28,30,31 Several investigations support that PEW is a result of
the chronic inflammatory processes that occur in patients with ESRD.10,28,30,31Although
pro-inflammatory cytokines are known to play a pivotal role by connecting inflammation
and malnutrition;28,32 additional factors, including stress-induced by oxidative-carbonyl
group imbalances, toxicity related to uremic load, metabolic acidosis and several
nutrition imbalances, greatly contribute to this complex link.29-31,33,34 It has been
suggested that there is more than one malnutrition in the context of renal disease.35 There
is the classic malnutrition, easy to identify, related to low protein and energy intake,
which can be improved with adequate nutrition and dialysis treatment; and a second type
of malnutrition, which is more difficult to diagnose and reverse with nutrition support.
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This second type of malnutrition is associated with the development of chronic
inflammation status and atherosclerotic cardiovascular disease. The successful treatment
of this type of malnutrition requires that the underlying comorbid conditions, including
chronic inflammation, are adequately and concomitantly treated as well.34,35 It is wellknown that many dialysis patients with chronic levels of inflammation develop a negative
protein balance, which further leads to weight loss, despite good appetite and adequate
intake.10,16,29,32 It has been suggested that in patients who report unavoidable weight loss
with adequate intake might be a change in the synthesis of protein from muscle to acutephase proteins as renal function deteriorates and uremia increases.32
The broad range of metabolic and nutritional responses to inflammation seen in
PEW, in the context of CKD-ESRD, are many and of great complexity, but of particular
interest is the exacerbated protein catabolism.30-32,35-37 Inflammation causes increased
energy expenditure, and pro-inflammatory cytokines are considered to have a
determinant role in lean body mass catabolism.36,37 For example, elevated interleukin-6 is
associated with increased proteolysis of the muscle cells.36 Albumin is inversely related to
the inflammation marker C-reactive protein, and pro-inflammatory cytokine levels and
oxidative stress could potentially lead to protein wasting.32-34 Anorexia, which leads to an
inadequate intake and weight loss, is a another well-recognized metabolic response to
inflammation that could lead to PEW.15,31,35,60 Therefore, chronic inflammation may be a
determinant factor that causally links PEW to increased morbidity and mortality among
dialysis patients.10,15,28-31,39 However, the degree at which there is a link between PEW
and inflammation and the independent effect of each upon adverse outcomes in patients
with kidney disease are unclear.38,39
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Chronic low-level inflammation is considered a frequent comorbid condition in
CKD and in dialysis patients, which has been associated with many different factors from
toxic uremic load to dialysis treatment itself.28 It has been proposed that in order to
achieve optimal nutrition among HD patients, periodic measurements of markers of
inflammation are useful to assess the severity and frequency of the inflammation status in
patients with PEW. Ikizler,40 in his most recent review of “Optimal Nutrition for dialysis
patients,” suggested that, regardless of the method used, it is extremely important to
guarantee repeated measurements and standardization of the techniques to reduce
variability. The author emphasized that the results should always be analyzed considering
the clinical setting and nutritional status of each individual patient.40

Neutrophil-to-lymphocyte ratio (NLR) as a useful marker of inflammation and
predictor of outcomes
The critical role of inflammation in the development of cardiovascular disease
and atherosclerosis, and its association with malnutrition in patients with renal disease,
has been supported by extensive evidence-based data gathered by a variety of research
studies.22,28,26,33,34,39,40 However, there is no consensus on how to assess the severity of
inflammation, and several measurements of inflammation have been used in both CKD
and dialysis patients.28,39,40
NLR has emerged as a subrogate marker for systemic inflammation, and its
associations with known inflammatory biomarkers has been investigated in patients with
different stages of kidney disease.41 NLR is a cost effective and very simple marker,
which it is calculated by dividing neutrophil to lymphocyte counts, which are obtained
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usually from peripheral blood samples. This convenient parameter allows for an easy
assessment of a patient’s inflammatory status.41,42
The association between NLR and pro-inflammatory cytokines, including among
others tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) levels, has been
demonstrated by studies conducted in pre-dialysis and dialysis patients.41-44 NLR levels
seems to predict worsening of renal function among diabetics.45,47 This novel marker has
shown a strong predicting value for adverse major cardiovascular events by means of
establishing a stratification criteria for mortality-associated risks after procedures such as
coronary artery bypass grafting.46 It has also proven to be an important prognostic factor
in several types of cancers,48,50,51 and it was found to be significant predictor of all-cause
mortality in multiple chronic conditions.49
The usefulness of NLR in the settings of dialysis treatments is an emerging novel
topic in the literature. It was demonstrated to have a strong predictive-value for
cardiovascular events and all-cause mortality in HD patients.52-56 The relationship with
other inflammatory markers, particularly, albumin and C-reactive protein was illustrated
by Malhotra et al.,43 who analyzed the results from two different international cohort
studies within the Monitoring Dialysis Outcomes research collaboration which included
43,272 HD patients. The authors compared the predictive ability of NLR versus elevated
C-reactive protein (CRP), a well-established marker of inflammation. These analysis
showed that NLR was adequate for diagnosing inflammation in settings where CRP is not
measured routinely, and supported that NLR can serve as a potential surrogate marker for
inflammation and adverse outcomes among HD patients.43An et al.52 examined the
predictive value of NLR for mortality among 86 PD patients in China and found that
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elevated NLR greater than 4.5 was associated with arterial stiffness and a strong predictor
of cardiovascular and all-cause mortality in this population.
In another prospective cohort study conducted in Japan, Kato et al.53 investigated
the association between NLR at the start of dialysis therapy with some clinical
biomarkers in 86 Japanese dialysis patients for an average 38.7 months of follow-up and
found that a higher NLR was associated with increased risk of cardiovascular disease
(CVD) events, and that index was a stronger predictor of future events. In this study the
authors compared the prognostic power of NLR with nutrition (SGA, albumin) and
inflammation (CRP and interleukin 6) markers and found that NLR was a superior maker.
Based on these results, the author concluded that NLR was a useful marker for
identifying patients at risk of CVD.53 Similar results have been published more recently
by Li H. et al.,54 who included 280 HD patients in China; by Brendo et at.,55 who
included 203 HD patients in Australia and by Erden et al.,56 who included 95 HD
patients in Turkey. All studies mentioned above found that an increased NLR (greater
than 3.5, 4.0 and 3.5; respectively) were strong predictors of mortality in this population.
Several NLR cut-off values obtained by different methods and in different
populations suffering from a variety of chronic conditions such as cancer, diabetes, CKD,
HD or PD or other debilitating conditions are recently cited in the literature and have
proven to be clinically meaningful.40-56 However, no consensus and universal cut-off
value is currently available.57 It remains unknown which NLR value is correlated with
higher risk for disease or inflammation, or which cutoff value will differentiate normal
from abnormal results and for which population will be a better predictor of adverse
outcomes.5
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Dietary intake in CKD and ESRD
Eating and drinking are required activities for species’ survival. It is vital to
provide the body with essential nutrients needed to maintain and repair tissues and cell
structures, and to provide fuel for energy-demanding processes and activities. In CKD
and ESRD patients as GFR decreases, a profound decline in protein and energy intake is
observed.58 The prevalence of anorexia has been reported as high as 30-55% in ESRD,59
as a consequence, there is an inadequate intake, which is an important cause of
malnutrition and itself related to adverse outcomes in ESRD.60-62 Araujo and
collaborators62 reported that a lower energy intake, at the start of hemodialysis,
constituted a very strong risk factor for 10-year mortality among ESRD patients. In
addition, anorexia, which a major cause for inadequate nutrient intake in ESRD has been
associated with 4 times higher risk of death and with increased morbidity in a study of
344 HD patients conducted by Kalantar-Zadeh et al. in the United States.31

Dietary intake assessment
The main reason for conducting dietary assessments in HD patients is to obtain
relevant information in relation to food, specific nutrients and diet patterns, and therefore,
being able to identify how patients can modify their diet to change associated health
risks.63-65 This information will help to determine whether patients are complying with
dietary guidelines and recommend changes in life-style and diet that are tailored to the
individual patient’s needs.65,66
Careful dietary assessment is needed for determining present and future
implications for individuals at risk for malnutrition.65 This may be of paramount
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importance in dialysis patients for whom the risk of death is high and strongly related to
malnutrition.66 Unfortunately, dietary assessments are not performed routinely in dialysis
patients, but they are essential and used extensively in research as they provide critical
information on diet quality, nutrient intake, and clinical endpoints.66 There are diverse
methods used to assess dietary intake in healthy populations and in those with chronic
diseases.67 The most frequent, universally used methods for dietary assessment in CKD
patients include dietary recalls (24-hour diet recall) and food records that are collected
during short periods of time between 3 to 7 days, and food frequency questionnaires
(FFQ), which are used to register average intake for longer periods of time (weeks to
month).67-69
The 24-hour diet record collects the most current information about food intake.65
A trained interviewer, usually an experienced dietitian, administers a questionnaire face
to face or through telephone interviews. The subject being interviewed is expected to
detail information about all the food and drink consumed during the past 24 hours. Very
often, different prompts are provided by the interviewer to aid the subject recall of actual
food and drink consumed, and portion sizes are usually included in the questionnaire.
Details about the cooking method, the use of additional items such as spread, sauces,
condiments, dressings are also collected. The main advantage of this method is its
convenience. It can be administered very quickly and could give as many details as
participant’s memory allows. The willingness to be accurate and detailed-oriented on
his/her answers and the reliance on the memory of the participants are the main
disadvantages.
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In addition, the level of comprehensiveness of the interviewer, as well as the
effectiveness of prompting techniques, substantially influence the accuracy of the
method.65,70 In some patients, especially in dialysis patients, whose diet intake pattern
may be significantly different on dialysis compared with non-dialysis days, it is
recommended to take several 24-hour recalls in order to generate more accurate averaged
data. This way, the collected 24-hour dietary intake information can be extrapolated to
longer periods.65,66,69,70
The assessment of the dietary intake of CKD patients has been the main purpose
of many early studies.61,71-75 Some of these studies compared the average patient intake
with KDOQI Clinical Practice Guidelines. For example; Cooper et al.71 and Lorenzo et
al.72 assessed the average dietary energy and protein intake in relation with KDOQI
recommendations by using food records. Both set of authors concluded that Dietary
Energy Intake (DEI) and Dietary Protein Intake (DPI) fall below nutrition
recommendations from KDOQI guidelines (30-35 kcal/day; 1.2 gm/kg/day). Lorenzo and
colleagues72 reported that 92% and 81% of participants did not meet the recommended
energy and protein intake, respectively. This study found a strong direct correlation
between DPI and DEI (r = 0.74, P< 0.0001) and a direct significant correlation between
serum albumin and DPI.72
Similar results have been described by Burrowes et al.,.73 who examined the
dietary intake of 1,901 patients and reported an average of daily energy intake of 22.7 ±
8.3 kcal/kg/day and protein of 0.93 ± 0.35 g/kg/day and concluded that most of the
patients did not meet current KDOQI dietary recommendations. Comparable results have
been reported in patients receiving PD74,75. Wang et al.,74 in a cross-sectional analysis of a
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cohort study that included 266 patients on PD, analyzed the participants’ intake using
FFQ and found greater average intake for energy and protein (25.1 kcal/kg/day; 1.11 ±
0.45 g/kg/day, respectively,) but still below KDOQI recommendations. Therrier et al.,75
in a secondary data analysis, found that the daily protein and energy intake of a PD
female group were significantly lower compared to the healthy female control group and
below KDOQI guidelines.
These studies summarized above clearly demonstrated that most dialysis patients,
including the two different treatment modalities, HD and PD, do not meet current
KDOQI recommendations for daily protein and energy intake, which may in turn
increase their susceptibility for PEW, that ultimately leads to adverse clinical outcomes
and death.74

Impact of quantitative nutrition deficiencies in outcomes of CKD-ESRD patients.
The significant association between inadequate diet intake and mortality has been
shown in several studies.74-79 Early in 1995, Davies et al.61 showed a strong association of
dietary energy and protein intake with mortality in patients treated with HD. Antunes et
al.76 investigated the association between dietary intake and mortality in 79 adult patients
receiving both PD and HD. This study revealed the impact of energy deficiency in
outcome prediction, in which DEI was significantly lower in non-survivors than survivors
(P=0.008). In contrast, adequate protein intake (at least 1.2 g/kg/day) was associated with
increased survival in HD and PD patients.
Other controlled studies have found significant differences between HD patients
and control groups (healthy patients) but these differences lost significance when
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adjusted for ideal weight. This was the case of the study conducted by Cupisti et al.,77
who found significant differences in average daily energy and protein intake by
comparing HD patients with non-CKD patients; the differences in their intake
disappeared once DEI and DPI were adjusted for ideal weight.
Other authors have compared the dietary intake of hemodialysis patients with the
recommendations prescribed by the American Heart Association Guidelines to reduce
cardiovascular disease. Khoueiry et al.78 compared the dietary intake information of 70
HD patients with these guidelines and concluded that most patients did not meet diet
recommendations for reducing the risk of cardiovascular disease. The DIET-HD study,79
a prospective cohort study that enrolled patients from January 2014 to June 2017 and
included 9,757 adults treated with HD in Europe and South America, examined diet
components of dialysis patients and their relationship with dialysis outcomes. In this
study Saglimbene et al.79 reported that only one third of the participants enrolled
consumed the minimum amount of n-3 PUFA (1.75 g/week), which is recommended for
primary cardiovascular prevention. Even though participants had an insufficient intake of
this cardio-protector nutrient, the association between the insufficient intake of n-3 PUFA
and cardiovascular or all-cause mortality was not statistically significant in this cohort of
HD patients.79
In agreement with multiple studies that have examined DEI and DPI in HD and
PD patients, most dietary intakes of patients receiving both dialysis modalities fall below
nutrition recommendations from KDOQI. Moreover, some of the studies have shown
association between patient’s diet intake and mortality. Deficient intake, in part ascribed
to diminished appetite or many other constellations of physiological or metabolic
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abnormalities can be attributed to the onset and development of PEW. Nonetheless, it
remains to be elucidated to what extend the inadequate intake of energy and protein can
be causally linked to increased morbidity and mortality.10,29

Dietary quality indexes
Diet quality is determined by food choices. A high diet quality consists of, but it
is not limited to whole grains and legumes, lean meat cuts, fresh fruits and vegetables and
low to moderate fat milk consumption.80 Some components that can affect the quality of
the diet are the low intakes of vitamins, minerals, healthy fats, whole grains and
phytonutrients in general; then, when a diet has poor quality, the concern for developing
chronic diseases rises.79-81 Hence, investigators in the field of nutrition research, based on
the prevailing hypotheses about the role of diet in disease prevention, have utilized the
principles underlying diet quality to investigate the potential association of diet quality
patterns with morbidity and mortality.79-82
Diet quality indexes and studies of dietary patterns have arisen as useful and
reliable approaches to evaluate not only the adequacy of dietary intake and the adherence
to current dietary guidelines, but also to explore the relationship between diet and health
outcomes.81-83 The identification of dietary patterns and the evaluation of the overall diet
quality become particularly important for examining the role of diet in the development
of chronic diseases. Some studies have used diet quality indices based on the American
Dietary Guidelines for diabetes and on heart disease and cancer disease prevention, while
other indices are adapted to reflect the dietary guidelines of other countries.79 Wellknown healthy dietary patterns such as vegetarian, Mediterranean, and dietary approach
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to stop hypertension (DASH) have shown to be associated with a reduced risk of
developing chronic diseases.83-87 The interest around the relationship of diet to outcomes
has expanded to the field of renal outcome research and has increased awareness of the
potential harm of innumerable dietary restrictions that characterized the standard renal
diet.78 Studies have examined the relationship between indices of diet quality and the
progression to ESRD in individuals with CKD and the risk for mortality in ESRD
patients.88, 89,94-102 In a cohort study of older adults with CKD- ESRD living in the United
States, the authors reported that a healthy diet, determined by the use of several different
indices, is associated with a reduced risk of kidney-associated death and with the
initiation of dialysis.89 The greater the quality of the diet, the better the outcomes.87,89,93 A
recent meta-analysis of cohort studies provided sound evidence that quality dietary
patterns are strongly associated with higher survival in people living with ESRD.90

The Alternative Healthy Eating Index (AHEI)
The Alternative Healthy Eating Index (AHEI)91 was created in 2002 to reflect the
Dietary Guidelines for Americans and it is constituted by 12 components. The component
scores are added to form a total score with a maximum of 100 points. The minimum
score (2.5) represents the worst adherence and the maximum score (87.5) represents the
best adherence to the guidelines. This scoring metric system was designed to measure
diet quality, based on foods and nutrients that are predictive of chronic disease risk.91 The
AHEI is a standardized tool that can be used in nutrition interventions, monitoring and
research in different populations with different chronic conditions.91-94 Huffman, et al.94
used this index to predict the risk of cardiovascular heart disease among Cubans with and
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without diabetes living in South Florida. In another study, Chiuve et al.95 measured the
association between the AHEI and the risk of chronic disease in 71,495 women enrolled
in the Nurses’ Health Study and 41,029 men enrolled in the Health Professionals FollowUp Study. All participants were free of chronic diseases at baseline. In this prospective
analysis, which included a large sample size, AHEI was strongly associated with the
development of coronary heart disease, diabetes, stroke and cancer. Based on the results,
the authors recommended the use of AHEI to assess the quality of the diet and to modify
the diet using the results of the score. This practice will improve the overall nutrient
quality of the diet and decrease the vulnerability of this population to develop other
chronic diseases.95

Consequences of qualitative deficiencies in nutritional intake in CKD-ESRD
patients
In the literature of diet quality in the context of CKD and ESRD, there is
mounting, emerging evidence suggests that healthy dietary patterns are associated with
improved survival in this special population, which is afflicted by a high rate of
mortality.95-98 Chiu et al.96 developed a quality index specially for dialysis patients in
Taiwan, called Hemodialysis Eating Index (HDEI). This specific index reflects the
adequacy of the dietary recommendations from the U.S. National Kidney Foundation that
was adapted to include the Taiwanese 2011 Daily Food Guide. Through a prospective
study, the authors examined the risk factors associated with cardiovascular disease that
were related to dialysis treatment. This HDEI index is composed by a total of 12 items,
including the daily servings of vegetables and fruits, nuts and soy, whole grains, high-
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protein foods, read meat, fish and white meat; among the considered items. The authors
also considered the daily consumption of fish oils, saturated and trans fatty acids, plus the
duration of the use of multivitamins.96 This study included 108 participants who were
further divided for the analyses into two groups based on the median value of the total
HDEI score, which was 72.2. After a two-month follow-up, the group with the higher
HDEI (above 72.2) exhibited a significant decrease in the serum cholesterol and an
increase in hemoglobin blood’s levels. The analysis of the relationships of the total HDEI
score and its individual components with nutritional parameters demonstrated a direct
correlation with serum albumin, which is a well-established nutritional marker for
morbidity and mortality in this population.96 Based on the results of their study, the
authors proposed that HDEI can be used as a reliable and sensitive tool for nutrition
assessment and intervention, hence, effectively preventing CVD in HD Taiwanese
patients.
The Japan Dialysis Outcomes and Practice Patterns Study (JDOPPS) is a large ongoing, observational study that registers and analyzes the dialysis outcomes from
hemodialysis patients across Japan. Tsuruya and colleages97 compared the diet of 1,355
participants in the JDOPPS with the diet of over 3000 non-dialysis participants (healthy
individuals) and identified common dietary patterns. This study also examined the
associations of diet parameters with clinical outcomes. Three different dietary patterns
were pre-determined as “well-balanced”, “unbalanced”, and “other”. The authors found a
significant direct association between eating an “unbalanced diet” and the risk of
developing important cardiovascular clinical events, including arrhythmia, cardiac
valvular disease, cardiac myopathy, pericarditis and congestive heart failure among
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others (HR=1.90, 95% C.I. 1.19-3.04). The authors concluded that “unbalanced” dietary
patterns increase the susceptibility for morbidity and mortality in hemodialysis patients.
Smyth et al.,98 in a 14-year follow-up study, evaluated the impact of diet quality
and specific diet components, including sodium and potassium intakes, on major renal
outcomes in a community dwelling adults living in six different states and two urban
areas in the United States. The study included a total of 544,635 participants aged 51 to
70 years who were enrolled in the American Association of Retired Persons (AARP) diet
and health study funded by the National Institutes of Health (NIH). The authors assessed
diet quality of the participants using different indexes: the Mediterranean Diet Score
(MDS), Recommended Food Score (RFS), Dietary Approaches to Stop Hypertension
(DASH) and AHEI. Death and dialysis initiation were the endpoints of this study. A total
of 4,848 deaths related to renal-cause or initiated dialysis were registered. By using a
multivariable Cox regression model to explore the association between these outcomes
and the quality of diet, it was concluded that diet quality represented by the score of
AHEI, HEI, MDS, and DASH, were significantly associated with outcomes. These
findings support a relationship between healthy dietary patterns and a reduced risk of
developing poor outcomes in the settings of renal diseases. The authors concluded that,
when it comes to the management of the diet of CKD patients, the quality of the diet
matters the most.98
Hyerang et al,99 in a cross-sectional study, assessed the quality of the diet in 62
patients from Seoul Korea receiving hemodialysis. The authors employed the Dietary
Quality Index (DQI) and examined the contributors of the individual nutrients to the
overall diet quality index. The authors reported inadequate energy intake in most

38

participants and that consumption of essential vitamins, minerals and nutrients, such as
vitamin A, C, B1 (thiamin), B2 (riboflavin), B3 (niacin), folate, calcium, phosphorus,
zinc and dietary fiber were inadequate among most subjects. The average of the DQI in
this cohort of HD patients was very low and the consumption of vegetables and fruit
groups were especially low compared with other food groups. The main contribution of
this study was demonstrating that insufficient calorie intake was the single most limiting
factor for improving diet quality.99
Wai et al.100 examined diet quality using an index called the “Heart-Wise Dietary
Habits Questionnaire” (DHQ) and investigated the relationship between dietary patterns
and renal-related clinical outcomes in CKD patients. Similar to the results from the
previous study that used the DQI,99 this study also found that all-cause mortality had a
significant association with intake of fruits and vegetables (HR: 0.35; 95% CI, 0.150.83). The authors confirmed the beneficial effects of eating adequate amount of fruit and
vegetables on reducing cardiovascular-associated mortality. In addition, the authors
recommended that limiting alcohol consumption and consuming adequate intake of fruits
and vegetables seemed to delay disease progression to more advanced stages. According
to Hyerang et al.99 and Wai et al.,100 adequate fruit and vegetable intakes improve
survival in patients living with CKD disease.100
Another version of the Diet Quality Index (DQI) was employed by Fernandez and
colleagues101 to reflect the adequacy of the Brazilian dietary guidelines in patients with
renal failure. In this cross-sectional analysis of 3-day food records of 100 CKD patients,
the authors evaluated DQI and its components. As in previous reports, lower diet quality
represented by lower DQI scores corresponded to lower adequacy of specific nutrients
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and food-group intake such as sodium and vegetables intake, whereas higher DQI scores
corresponded to adequate intake of meat/egg, legumes and vegetables. The authors
concluded that the diet quality of this cohort of patients was poor and inadequate in
vegetables composition, food variety, and sodium intake.101 Reports from studies
focusing on discovering a potential relationship between the diet of patients living with
kidney disease and outcomes have suggested, through different methodologies and
analyses, that poor diets may lead to poor nutritional status and worse health outcomes.98103

Despite the variety of indices used to evaluate the diet quality of patients, and
their presumable connection to patients’ nutritional status and health outcomes;98-102 it is
still not clear which specific diet quality index is a stronger predictor of morbiditymortality in HD hemodialysis.101 Hence, the potential prognostic implications of the
adequacy of the quality and quantity of the diet in relation to the clinical outcomes of this
population warrants further studies.29,100,103

Summary
There is a large body of evidence in the literature of the relationship between the
high prevalence of both, morbidity and mortality, and the nutritional status of ESRD
patients,8 where inflammation and/or dietary intake seem to be crucial additional
predictors for disease-related outcomes.10,13 However, factors generating these
interrelationships are not well understood and mechanisms for these relationships are
lacking. The substantial restrictions and poor diets of patient receiving hemodialysis may
be important contributors to poor nutritional status and worse survival, however, there is
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an important and still undefined role for inflammation and metabolic abnormalities to
affect and modify PEW.29
Thus, to achieve optimal nutrition among HD patients it is necessary to
systematically assess their diet and nutrition status. In addition, periodic measurements of
markers of inflammation can be useful to assess severity and frequency of inflammation
in patients who are at risk for developing PEW.4 Studies that examine the
interrelationship between dialysis outcomes, nutritional status, inflammatory biomarkers,
and the interplay of diet quality and quantity, such as the study conducted and described
in this dissertation, are needed.
Most of the studies being discussed in this review of the literature have several
limitations that demand further research, including small sample sizes, indirect
measurements of dietary intake, inconsistent or contradicting findings, and crosssectional design.
Determining impact of an inadequate nutritional intake of hemodialysis patients in
development of the PEW syndrome is clear; as its strong association with morbidity and
mortality. Though, the implication of low diet quality for outcomes, and its interrelation
with inflammation status in the literature is contradictory.64 Adequacy in nutritional
intake and healthy dietary eating patterns that facilitate the supply of nutrients needed for
cardiovascular, gut and immune health may have positive prognostic implications for
patients’ health, through mechanisms independent of BMI or protein status.29 Therefore,
it is important to examine the relationships that exist between inflammation, nutritional
status and the interplay of quality and quantity of the diet, to shed a light on the plausible
mechanisms involved in these associations. Consequently, furthering the knowledge that

41

we have on these relationships may be translated into clinical meaningful assessments
and relevant diet recommendations to improve the well-being of patients living with
hemodialysis.
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CHAPTER III: ASSOCIATION BETWEEN NEUTROPHIL-TO-LYMPHOCYTE
RATIO, NUTRITION PARAMETERS AND HEALTH OUTCOMES IN
HEMODIALYSIS PATIENTS
Abstract
Objective: Adverse outcomes in hemodialysis patients have been attributed, in part, to
the pro-inflammatory state prevalent in this population. This study examines the
relationship between neutrophil-to-lymphocyte ratio (NLR) with nutrition parameters and
health outcomes in hemodialysis (HD) patients.
Design: This is a 12-month prospective cohort study that recruited 77 participants from
May to Jun 2017.
Settings and subjects: Patients receiving maintenance hemodialysis.
Main outcomes: Hospitalization, transplants and mortality.
Results: Of the 77 participants, 63.8% were hospitalized, 10(13%) died of cardiovascular
diseases and 6(7.8%) had a kidney transplant. Hospitalized participants had lower mean
BMI kg/m2 at baseline compared to those not hospitalized (26.22 ± 5.34 vs 29.11 ± 5.4,
P=0.026) and the percentage of patients with the lowest level of inflammation (NLR ≤
1.75) was greater for not hospitalized patients than for hospitalized (39.3% vs. 16.3%,
P=0.025). Spearman’s correlations showed an inverse correlation between NLR and
albumin (rho= -0.218, P=0.028); and a direct correlation between NLR and BMI
(rho=0.22, P=0.026 ). Participants were grouped by their NLR value into quartiles for
outcomes analysis: quartile 1 (NLR ≤1.75), quartile 2 (NLR 1.76-2.6), quartile 3 (NLR
2.7-3.9) and quartile 4 (NLR ≥ 4). In a multivariate cox regression analysis, participants
in the lowest quartile (NLR ≤1.75) were compared to the rest on hospitalization,
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mortality and transplant. Years in dialysis, BMI kg/m2 and NLR ≤ 1.75 were significant
predictors of hospitalization after adjustment (P=0.021, P=0.005, P=0.039; respectively)
and we observed an association of low NLR with a hazard ratio (HR=0.44, 95% CI 0.200.96, P= 0.039), BMI (HR=0.90, 95%CI 0.85-0.97, P=0.005) and years in dialysis
(HR=0.90, 95% CI 0.83-0.98, P=0.021) for hospitalization in overall participants. In a
further analysis comparing the effect of low NLR in the subgroup of diabetic participants
versus non-diabetics, it was observed that BMI kg/m2 was a significant predictor for
hospitalization in the non-diabetic subgroup (P=0.04) but not significant in the case of
diabetic(P=0.128) after adjustments. The covariates, years in dialysis and NLR ≤ 1.75
were significant predictors of hospitalizations in the subgroup of diabetics participants
after adjustment (P=0.049, P=0.044; respectively). Thus, NLR ≤ 1.75 was only
significant among diabetics. Survival and hospitalization curves were analyzed by
comparing all participants in the lowest inflammation quartile versus the rest (NLR ≤
1.75 vs NLR >1.75). Participants with NLR ≤ 1.75 had 100% survival rate (log-rank test,
P=0.059) and lower hospitalization rate (log-rank test, P=0.025). Participants with
diabetes in the lowest inflammation quartile (NLR ≤ 1.75) had lower hospitalization rate
compared with participants with diabetes in the higher inflammation quartiles
(NLR>1.75) (log-rank test, P=0.039). Having a low NLR decreases 73% the risk for
hospitalization in this subgroup of diabetics HD participants (HR =0.27 95% CI 0.070.96, P=0.044).
Conclusion: NLR at baseline was associated with nutritional markers (albumin, BMI)
and was a predictor of hospitalizations only for diabetic patients. Low NLR at baseline
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was a predictor of lower risk of hospitalizations during 12 months in HD patients with
diabetes.

Introduction
Patients with end-stage renal disease (ESRD) receiving dialysis exhibit a high
hospitalization rate – approximately two admissions yearly per patient – and a 20-25%
mortality rate with a 5-year survival rate of 35%.1, 2 In this population, cardiovascular and
infectious diseases account for approximately 50% and 20% of deaths, respectively.1
These outcomes have been attributed, in part, to the prevalent pro-inflammatory state that
afflicts patients living with dialysis, including uremic burden, abnormal levels of
circulating pro-inflammatory cytokines, oxidative-carbonyl stress, protein-energy
wasting, increased incidence of infections, and anemia.3,4 Inflammation has been
implicated in the initiation and progression of atherosclerosis and in cardiovascular
mortality through leukocyte adhesion and infiltration of the vascular endothelium.5,6 In
hemodialysis patients, T-lymphocytes and the antigen-presenting cell (APC) functions
are frequently impaired producing immune disturbances that may lead to inflammation
and metabolic imbalances that lead to malnutrition.7 The vicious cycle closed by
infections and subsequent malnutrition supported by inflammatory cytokines, may lead to
more frequent hospitalizations and ultimately to death. The important role of the impaired
immune system in these events is the mechanistic link to its relationship with the
Neutrophil-to-lymphocyte ratio (NLR).
Neutrophil-to-lymphocyte ratio (NLR) has emerged as a subrogate marker for
systemic inflammation in Chronic Kidney Disease (CKD) and ESRD.8,9 It is obtained by
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dividing neutrophil count by lymphocyte count, which makes it a cost effective, simple
parameter that allows to easily assess the inflammatory status of a subject.8 NLR has
demonstrated potential diagnostic capacity in settings where C-reactive protein is not
measured routinely.10 NLR has been useful in the stratification of mortality in major
cardiac events,11 as a strong prognostic factor in several types of cancers,12 and in the
prediction of worsening renal function in patients with diabetes.13 While the use of NLR
as a predictor of cardiovascular and all-cause mortality in patients receiving dialysis has
gained recognition, there remain many barriers to its robust application.14 The correlation
between NLR value and a higher adverse risk has not been thoroughly defined; it remains
unknown which cutoff value will discriminate normal from abnormal results and for
which population NLR will be a better predictor of adverse outcomes. The aim of this
study was to examine the relationship between neutrophil-to-lymphocyte ratio and
nutrition parameters with health outcomes in hemodialysis patients.

Methods
Design
A 12-month prospective cohort study was conducted at one hemodialysis clinic
located in South Florida. The study protocol was approved by the Florida International
University Institution Review Board (FIU-IRB) and informed consent was obtained from
each patient. The sample consisted of all adult male and female patients recruited from
May to Jun 2017, who agreed to participate in the study and met the inclusion criteria,
which were to be 19 years of age or older, undergo hemodialysis three times per week for
at least three months and being medically stable without acute infection. Participants
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were excluded if they were receiving nutrition support (intradialytic parenteral nutrition)
or enteral nutrition, had dementia interfering with completing the nutritional
questionnaire, or refuse to participate or perform study activities.

Demographic and Clinical data
Clinical and demographic data were collected from clinical charts and through
interviews with the patients. The demographic data collected from clinical charts
included age, gender, ethnicity, hemodialysis start date, BMI kg/m2, and diabetes mellitus
diagnosis.
The biochemical data included serum albumin, net protein catabolic rate (nPCR),
neutrophils and lymphocytes percent, total iron binding capacity (TIBC), and dialysis
adequacy (Kt/V). All these values were collected at multiple time points for 12 months.

Endpoints: Hospitalization, transplants and mortality
Hospitalization was defined as any hospital stay lasting one night or longer. The
occurrence of hospitalization was verified over 12 months as well as kidney transplant
and death (all- cause mortality).

Statistical analysis
We report absolute and relative frequencies, mean, standard deviation, median,
and interquartile range assuming data normality. For the inferential statistics, normal data
distribution was first determined using the Kolmogorov-Smirnov test and the equality of
variances was confirmed using Levene's test. One-way ANOVA, Student’s t tests, chi-
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square tests, or Mann-Whitney tests were used to compare variables between groups, as
appropriate. Only baseline values were included in the correlation analysis of albumin,
nPCR, NLR, TIBC and Kt/V and in the statistical models for endpoint analysis.
Spearman correlations were used for bivariate analysis. Significant outcome’s predictors
were identified and further analyzed in univariate and multivariate models, and then a
forward stepwise cox regression identified the most parsimonious model. The probability
used for the stepwise regression was set at 0.05 for entry of variables and 0.10 for
removal. Survival and hospitalization (time to first hospitalization) curves were estimated
by Kaplan-Meier analysis and compared using the log-rank test. The hazard ratios were
obtained from cox regression analysis. The level of statistical significance was P<0.05.
All statistical tests were performed with SPSS version 20 software (IBM Corp., Armonk,
NY, USA).

Results
Demographic analysis
Seventy-seven hemodialysis participants were enrolled in this study, with a mean
age of 63.2 ± 15.7 years; 28.8% were female, 18.2% were Hispanics, 39% were African
Americans, 31.2% were Whites and 11.7% were West Indian. Their average time
receiving dialysis was 6.2 ± 4.2 years, and 58.4% of the patients had diabetes. In terms of
dialysis parameters, the hemodialysis doses and duration were similar for all patients.
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Endpoints analysis: Hospitalization, mortality and transplants
During the planned 12-month monitoring period, 6 participants (7.8%) were
terminated due to kidney transplant, one participant (1.2%) was transferred to another
dialysis center, and 10 (13%) died of cardiovascular diseases (CVD).
The percent of participants who were hospitalized during the study was 63.8%
with a mean ± SD of 1.1 ± 0.73 hospitalizations per patient per year (PPY); 38% of the
participants were admitted only once, 10% were admitted twice, and 14.2% were
admitted three times or more. The causes of hospitalizations varied from infections
(48.5%), and other causes (51.5%) such as gastrointestinal issues, access-related issues,
fluid overload and planned surgeries among others. The length of the hospitalization was
not recorded for any case. The mean values of the biochemical variables, including
albumin, nPCR, NLR, TIBC and Kt/V, were compared at baseline, 6 months, 12 months
and year average, and no statistically significant differences were detected. (All Ps> 0.05,
data not shown)
Spearman correlations were determined among total number of hospitalizations
registered in 12 months and baseline values of BMI kg/m2, albumin, nPCR, NLR, TIBC.
There was an inverse significant correlation between the total number of hospitalizations
and BMI kg/m2 (BMI: rho=-0.37, P<0.001). Correlations between total numbers of
hospitalizations with albumin, nPCR, NLR, and TIBC, did not achieve statistical
significance (albumin: rho =-0.04, P=0.36; nPCR: rho =-0.13, P=0.14; NLR: rho=0.16,
P=0.07; TIBC: rho=0.18, P=0.06). We found a significant inverse correlation between
NLR and albumin (rho =-0.22, P=0.028); and a significant direct correlation between
NLR and BMI kg/m2 (rho=0.22, P=0.028).
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Participants were grouped by their NLR value into quartiles for the analysis of
NLR as a marker of inflammation and endpoints (Table 1): quartile 1 (NLR ≤1.75),
quartile 2 (NLR 1.76-2.6), quartile 3 (NLR 2.7-3.9) and quartile 4 (NLR ≥4). Baseline
cohort characteristics, including demographic and baseline biochemical variables, are
summarized in Table 1. Those examined variables that showed significance level with a
P ≤ 0.2 (one-way ANOVA and chi-square test) and pre-determined variables, were
further analyzed in multivariate and a stepwise cox regression model (Table 3).
Table 2 shows a comparison between hospitalized and not hospitalized patients.
The BMI kg/m2 (mean±SD) for not hospitalized patients was significantly higher than for
hospitalized (29.1± 5.4, 26.2 ± 5.3; P=0.026). The percent of participants with the lowest
level of inflammation (NLR ≤ 1.75) was greater for participants who were not
hospitalized than for those hospitalized (39.3% vs. 16.3%, P=0.025). No statistically
significant difference was detected between participants who had at least one
hospitalization and participants who did not have any hospitalization during the period of
the study by age, gender, years in dialysis, diabetes, ethnicity, albumin, nPCR, TIBC and
Kt/V, (all Ps>0.05).
Table 3 shows a multivariate cox regression analysis that was constructed to test
the contribution of each pre-determined variable to the dependent variable (all causehospitalization) in the entire cohort. Significant predictors were subsequently added to
the multivariate model and forward stepwise Cox regression, which identified the most
parsimonious model. The probability used for the stepwise regression was set at 0.05 for
entry of variables and 0.10 for removal. Years in dialysis, BMI kg/m2 and NLR ≤ 1.75
were significant predictors of hospitalization after adjustment. We observed an
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association of lower NLR (HR=0.44, 95% CI 0.20-0.96, P= 0.039), higher BMI
(HR=0.90, 95%CI 0.85-0.97, P=0.005) and more years in dialysis (HR=0.90, 95% CI
0.83-0.98, P=0.021) with hospitalization (Table 3).
Table 4 shows a multivariate cox regression analysis that was constructed to
evaluate the contribution of each pre-determined variable to the dependent variable (all
cause-hospitalization) in the subgroup diabetics versus non-diabetic participants.
Following the same analysis, significant predictors were subsequently added to the
multivariate model and forward stepwise cox regression identified the most parsimonious
model. The probability used for the stepwise regression was set at 0.05 for entry of
variables and 0.10 for removal. In this analysis, BMI kg/m2 was a significant predictor
for hospitalization in non-diabetic subgroup (P=0.040) but not significant in the case of
diabetics (P=0.128) after adjustments. The covariates, years in dialysis and NLR ≤ 1.75
were significant predictors of hospitalizations in the subgroup of diabetics participants
after adjustment (P=0.049, P=0.044; respectively). Thus, when the effect of low NLR
was compared diabetics to non-diabetics, NLR ≤ 1.75 was only significant among
diabetics. Having a low NLR decreases 73% the risk for hospitalization in this subgroup
of participants (HR =0.27 95% CI 0.07-0.96, P=0.044) (Table 4).
In addition, to analyze the effect of the lowest level of inflammation on the
endpoints of the study; survival and hospitalization curves were analyzed by comparing
participants in the lowest quartile of inflammation versus the rest (NLR ≤ 1.75 vs NLR
>1.75). Figure 1(A) the Kaplan-Meier curve for mortality. Participants with NLR ≤1.75
had a marginal significant 100% survival rate (log-rank test, P=0.059). Figure 1(B) shows
the hospitalization curve comparing all participants in the lowest quartile of inflammation
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versus the rest. Participants in the lowest quartile had a lower hospitalization rate (logrank test, P=0.025). When the subgroup of diabetics was analyzed; participants with
diabetes and in the lowest quartile of inflammation (NLR ≤ 1.75) had lower
hospitalization rate compared with participants with diabetes in the higher quartile of
inflammation (NLR >1.75) (log- rank test, P = 0.039) (Figure1(C)). In total, there were
10 deaths in this cohort in 12 months: seven of them from quartile 2 and two from
quartile 3 and one from quartile 4. Survival was 100% in the lowest quartile of
inflammation (quartile, NLR ≤ 1.75). Further analysis may be needed with a larger
sample and/or over longer period to clarify the role of inflammation on these particular
health outcomes. Kaplan-Meier hospitalization curves still supported the findings that
level of inflammation is predictive of hospitalization but not of mortality, [Figure 1 (A)
(B) (C)]. Participants with NLR ≤ 1.75 had lower hospitalization rate compared with
participants with greater NLR levels (log-rank test, P=0.025) and this protective effect
was more significant for diabetic participants (log- rank test, P = 0.039).

Discussion
Several adverse clinical outcomes have been associated with systemic
inflammation markers in CKD and ESRD, including cardiovascular events, kidney
disease progression, anemia, protein energy wasting, and all-cause mortality.7,10,13 In this
study, we evaluated the predictive value of NLR for health outcomes: hospitalization,
transplant, and mortality in patients receiving hemodialysis. The results indicated that
NLR was a significant predictor of hospitalization in diabetic patients. Our results
support previously reported findings that show the usefulness of this novel marker in
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outcomes prediction. NLR has been shown to be a strong and independent predictor of
cardiovascular disease severity and mortality in the general population10 In 2012, AnX. et
al.15 reported the predictive value of NLR for cardiovascular mortality in patients
receiving peritoneal dialysis, and more recently, in 2017, Han Li et al.16 found that NLR
was an independent predictor of cardiovascular risk and mortality in patients receiving
maintenance hemodialysis. In 2013, Erdem et al.17 also reported the usefulness of NLR in
predicting short-term mortality among Turkish patients receiving hemodialysis in a
hospital setting. However, in our study, the effect of NLR on mortality did not reach
significance.
The hospitalization of hemodialysis patients in the United States varies from 51.0
to 67.0%.1 In our cohort (N=77), the percent of participants who were hospitalized was
63.8% and mean hospitalization patient-per-year (PPY) was 1.1 ± SD 0.73, which is
below the adjusted rate of hospitalizations for hemodialysis patients reported in 2014,
which was 1.7 PPY.1 When we compared the hospitalization rate of participants in the
lowest level of inflammation versus the rest, we found that a low NLR had a significant
protective effect among patients with diabetes. Interestingly, a similar significant effect
was not observed in participants without diabetes. In agreement with our findings, Azab
et al., in two long-term follow-up studies, analyzed the usefulness of NLR specifically for
patients with diabetes and reported a correlation between high NLR and worsening of
kidney function.13,18 Furthermore, they found that NLR was a predictor of major adverse
cardiac events among patients with diabetes with stage five kidney disease.18
While our analyses did not reveal a significant correlation between inflammation
and mortality, there seems to be a possible effect to be further investigated, as there were
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no deaths in the lowest NLR quartile, and the ten deaths registered during the study
occurred in the higher NLR quartiles. The reason behind this finding needs to be studied
in the future with a larger sample size.
Our study also showed an unusual relationship between BMI kg/m2 and number
of hospitalizations; as BMI kg/m2 increased, the number of hospitalizations decreased
(rho= -0.37 P<0.001).This trend has the opposite direction to that observed in the general
population, where the higher the BMI, the greater the risk of morbidity and mortality.19
This epidemiological paradox, in which high BMI kg/m2 is associated with improved
survival, is found in patients with CKD and undergoing hemodialysis and it has been
previously reported.20, 21
In our cohort, participants with higher BMI kg/m2 had 10% lower risk of
hospitalization (HR=0.90, 95% 0.85-0.97, P=0.005), and participants with greater
number of years in dialysis had less risk for hospitalization (HR=0.90, 95% CI 0.83-0.98,
P=0.021). This might suggest that, in hemodialysis patients with increased BMI,
increased body fat, and more years in dialysis is related to less adverse events that
ultimately require hospitalizations. The known 5-year survival rate is 35% for ESRD
patients;1 therefore, long-term survivors seem to be more stable and resilient to
hospitalization in our cohort. Not hospitalized patients had a mean of 7.1 ± SD 4.8 year in
dialysis versus 5.6 ± SD 3.7 for participants who were hospitalized, at least once, in 12
months. This difference became significant after adjustment (P=0.021) for all participants
(Table 3) and for diabetics (P=0.049) (Table 4).
NLR had an inverse correlation with albumin (rho = -0.218, P = 0.028); and a
direct, significant correlation with BMI kg/m2 (rho = 0.222, P=0.026). The inverse
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correlations between several makers of inflammation and albumin are well established.22,
23

It has been known that albumin levels decrease with inflammation due to diminished

synthesis, augmented catabolism, and translocation of albumin to extravascular pools.23
Likewise, the direct correlation between BMI and markers of inflammation have been
reported recently in hemodialysis patients.24 This 12-month cohort study suggested that
NLR values were significantly associated with parameters of nutritional status and
inflammation (albumin and BMI) and hospitalizations. Lower quartile of inflammation
(NLR ≤1.75) predicted hospitalization and had a stronger protective effect in
hemodialysis patients with diabetes than in those hemodialysis patients without diabetes.
Inflammation characterized by increased levels of pro-inflammatory cytokines has
been recognized as having the potential for numerous complications in chronic dialysis,
including mortality.25, 26 The etiology of this observation remains unknown, and a
thorough understanding of the mechanisms behind this relationship between
inflammation and adverse outcomes needs to be more clearly explained, as this topic is a
continuous subject of current investigations and controversies.27, 28 In conclusion, the
knowledge that this study adds to close the gap in the renal literature, is that NLR is an
adequate novel marker of inflammation strongly associated with nutritional markers
(albumin, BMI) and is a predictor of hospitalizations. The mechanism through which
high or low inflammation influences the mortality and hospitalization rate of
hemodialysis patients, however, needs further elucidation.
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Limitations
The generalization of our findings to other hemodialysis populations are limited
by a small sample size of participants from only one clinic facility. Despite multiple
measures of NLR through 12 months, a longitudinal analysis of this marker needs to be
performed and only baseline values were examined as predictors. This study did not
compare the predictive strength of NLR with other potential inflammation markers, such
as C-reactive protein and interleukin-6, only with albumin. Further studies are needed to
answer which NLR cutoff values are clinically meaningful and for which population
NLR will be a better predictor of adverse outcomes.

Conclusion
Our study supports the use of neutrophil-to-lymphocyte ratio, an inexpensive and
convenient inflammation marker, as a predictor of adverse outcomes in hemodialysis
patients. This study provides significant information regarding risk factors for
hospitalization and confirms the protective value that a low neutrophil-to lymphocyte
ratio might have on the risk of hospitalizations in hemodialysis patients with diabetes,
identifying patients in need of intervention.
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Table 1: Baseline characteristics of the overall participants and comparing participants
grouped into NLR quartilesa
Variable

Baseline

overall

N= 77
Mean±SD

Age
62.3±12.7
Female
28.6%
Years in
6.2±4.2
dialysis
BMI
27.2±5.5
Diabetes
58.4%
Ethnicity:
Hispanic
18.2%
Black
39.0%
White
31.2%
West
11.7%
Indian
Albumin
3.8±0.3
Kt/V1
1.4±0.2
TIBC2
214±30
3
nPCR
0.9±0.2
NLR4
2.9±1.8
# Hosp. per
1.1±0.73
patient
Hospitalized
63.8%
Transplanted
7.8%
Mortality
13%

quartile 1

quartile 2

quartile 3

quartile 4

NLR
(£1.75)

NLR
(1.76-2.6)

NLR
(2.7-3.9)

NLR
(≥ 4.0)

N=18
Mean±SD

Pvaluesb

N=19
Mean±SD

N=21
Mean±SD

N=19
Mean±SD

62.4±12
36.8%
6.4±4.8

61.3±16
14.3%
6.8±3.9

64.8±13.9
22.2%
6.5±5.0

64.8±20.3
42.1%
5.1±2.9

0.861*
0.174**
0.598*

26.8±5.
42.1%

25.6±4.7
47.6%

28.8±5.9
66.7%

28.1±5.2
78.9%

0.290*
0.068**

10.5%
52.6%
15.8%
21.1%

19.0%
52.4%
14.3%
14.3%

22.2%
33.3%
44.4%
0.0%

21.1%
15.8%
52.6%
10.5%

0.024**

3.8±0.3
1.5±0.2
214±31
0.9±0.3
1.1±0.4
0.9±1.6

3.9±0.2
1.5±0.2
210±27
0.9±0.2
2.2±0.2
1.4±1.1

3.7±0.3
1.4±0.2
217±31
0.9±0.3
3.2±0.3
2.0±0.4

3.7±0.3
1.5±0.2
218±32
1.1±0.34
5.4±1.7
1.4±1.1

0.098*
0.396*
0.845*
0.147*
0.000*
0.628*

42.1%
10.5%
0%

90.5%
4.8%
33.3%

38.9%
11.1%
11.1%

78.9%
5.3%
5.3%

0.043**
0.820**
0.001**

*one-way ANOVA test **likelihood ratio chi-square test
aquartiles: quartile 1 (NLR £ 1.75), quartile 2 (NLR 1.76-2.6), quartile 3 (NLR 2.7-3.9) and quartile 4 (NLR ≥4.0)
bstatistically significant, P<0.05
1Kt/V=dialysis clearance, 2TIBC=total iron binding capacity, 3nPCR=net protein catabolic rate, 4NLR=neutrophil-tolymphocite ratio, #= number of hospitalizations per patient
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Table 2: Table of characteristic comparing not hospitalized versus hospitalized
Not Hospitalized
N= 28
mean±SD

Hospitalized
N=49
mean±SD

P-valuea

63.2±14.7
28.6%
7.1±4.8
29.1±5.4
50.0%

63.3±16.4
28.6%
5.6±3.7
26.2±5.3
36.7%

0.981*
0.607**
0.132*
0.026*
0.185**

Ethnicity
Hispanic
Black
White
West Indian

17.9%
46.4%
32.1%
3.6%

18.4%
34.7%
30.6%
16.3%

0.373**

Albumin
Kt/V1
TIBC2
nPCR3
NLR4
NLR4£1.75

3.7±0.3
1.5±0.2
207.5±30.3
0.9±0.2
2.6±1.7
39.3%

3.8±0.3
1.4±0.2
218.6±29.8
0.9±0.3
3.2±1.8
16.3%

0.501*
0.828*
0.141*
0.862*
0.215*
0.025**

Variable
Baseline
Age
Female
Years in dialysis
BMI
Diabetes

*student T test **chi-square test, astatistically significant, P<0.05
1Kt/V=dialysis clearance, 2TIBC=total iron binding capacity, 3nPCR=net protein catabolic rate, 4NLR=neutrophil-tolymphocite ratio.
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Table 3: Multivariate Cox regression model for all-cause of hospitalizations in all
participants
95% CI
Covariate

Age
Sex
Ethnicity
Diabetic
Years in
dialysis
BMI*
Albumin*
nPCR*3
TIBC*2
Kt/V*1
NLR4 ≤1.75*

95% CI

unadjusted
HRb

Lower

Upper

Pvaluea

adjusted
HRb

Lower

Upper

Pvaluea

0.99
1.00
1.16
1.42
0.94

0.98
0.54
0.84
0.79
0.88

1.01
1.87
1.59
2.55
1.01

0.869
0.985
0.349
0.229
0.134

0.90

0.83

0.98

0.021

0.94
1.39
0.74
1.00
0.82
0.44

0.89
0.49
0.26
0.99
0.19
0.20

0.99
3.92
2.08
1.01
3.53
0.95

0.044
0.525
0.573
0.137
0.794
0.038

0.90
0.44

0.85
0.20

0.97
0.96

0.005
0.039

*baseline
astatistically significant, P<0.05, bHR= Hazard ratio
1Kt/V=dialysis clearance, 2TIBC=total iron binding capacity, 3nPCR=net protein catabolic rate, 4NLR=neutrophil-tolymphocite ratio
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Table 4: Multivariate Cox regression model for all-cause of hospitalizations in diabetic
and non-diabetic patients
Covariate

un
adjusted
Hazard
ratio

95% CI
Lower
Upper

Pvaluea

adjusted

95% CI
Lower Upper

Hazard
ratio

Pvaluea

NON-DIABETIC
Age
Sex
Ethnicity
Years in
dialysis
BMI*
Albumin*
nPCR*1
TIBC*2
Kt/V*3
NLR4
≤1.75*

1.01
1.48
1.04
0.99

0.98
0.52
0.63
0.89

1.04
4.18
1.71
1.09

0.458
0.452
0.873
0.856

0.97

0.87

1.08

0.593

0.91
1.66
0.57
1.00
3.45
0.63

0.83
0.24
0.06
0.98
0.19
0.22

1.00
11.51
5.23
1.02
60.36
1.79

0.050
0.606
0.619
0.561
0.395
0.394

0.90
0.60

0.83
0.21

0.99
1.72

0.040
0.347

0.99

0.049

DIABETIC
Age
Sex
Ethnicity
Years in
dialysis
BMI*
Albumin*
nPCR*1
TIBC*2
Kt/V*3
NLR4
≤1.75*

0.98
0.72
1.20
0.91

0.96
0.33
0.82
0.83

1.00
1.58
1.90
1.01

0.240
0.425
0.295
0.082

0.89

0.80

0.97
1.45
0.93
1.00
0.50
0.33

0.90
0.43
0.28
0.99
0.08
0.10

1.04
4.87
3.06
1.01
2.89
1.11

0.398
0.540
0.911
0.240
0.441
0.075

0.93
0.27

0.85
0.07

1.02
0.96

0.128
0.044

*baseline
astatistically significant, P<0.05
1Kt/V=dialysis clearance, 2TIBC=total iron binding capacity, 3nPCR=net protein catabolic rate, 4NLR=neutrophil-tolymphocite ratio
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Figure A: Kaplan–Meier estimates of mortality for overall participants

Figure B: Kaplan–Meier estimates of hospitalization for overall participants
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Figure C: Kaplan–Meier estimates of hospitalization for participants with diabetes

Kaplan–Meier estimates of mortality and hospitalization. Participants stratified by two groups based on the neutrophillymphocyte ratio (NLR): quartile 1 corresponding to the lowest inflammation quartile (NLR ≤1.75) vs the rest of
quartiles (NLR >1.75).
Fig A showed that NLR was not associated with mortality (log- rank test, P=0.059)
Fig B showed that NLR was associated with hospitalization (log-rank P=0.025)
Fig C showed that NLR was associated with hospitalization in participants with diabetes (log- rank test, P=0.039)
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CHAPTER IV: NUTRITIONAL STATUS AND DIETARY INTAKE AS
PREDICTORS OF POOR OUTCOMES IN HEMODIALYSIS PATIENTS.

Abstract
Objective: Malnutrition is prevalent in hemodialysis (HD) patients, ranging from 16% to
62% depending on the methods used to assess nutritional status. There is a growing
evidence that malnutrition is a significant risk factor for morbidity and mortality in this
population. This study examines the predictive value of measuring dietary intake and two
assessment tools of nutritional status and their relationship with hospitalization and
mortality in HD patients.
Design: This is a 12-month prospective cohort study that recruited 77 participants from
May to Jun 2017.
Results: Fifty-five men and 22 women participated in this study; their mean age was 63.2
± 15.7 years. Their average time receiving dialysis was 6.2 ± 4.2 years and 58.4% of the
patients had a diagnosis of diabetes mellitus in their medical chart; 18.2% were
Hispanics, 39% were Black, 31.2% were Whites and 11.7% were West Indians. During
the period of the study (12 months) 63.6% of participants had at least one hospital
admission, 6 participants (7.8%) had a kidney transplant and a total of 10 participants
(13%) died, and all death-related causes were from cardiovascular diseases. Based on
SGA 55% were well-nourished and 45% moderate-to-severe malnourished. Based on
MIS 49% were well-nourished and 50.6% moderate-to-severe malnourished. Only 53%
of the participants met energy recommendations (ER). Comparing hospitalized versus
not hospitalized participants, those with higher BMI (29.11 ± 5.44 vs 26.22 ± 5.34;
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P=0.02), had greater SGA score (5.67 ± 1.44 vs. 4.81 ± 1.69; P=0.04) and lower MIS
score (5.25 ± 2.07 vs. 7.25 ± 3.69; P=0.01). SGA was associated with mortality
(HR=12.09, 95% CI=1.53-95.4, P=0.018) but this relationship lost significance after
adjustments (P=0.067). The association of SGA with hospitalization remained significant
after adjustments (HR=2.67, 95% CI=1.29-5.10, P=0.003). Participants with moderate-tosevere malnutrition based on SGA had a 2.67 hazard risk for having a hospitalization
event. MIS >5 was associated with hospitalization (HR=2.11, 95% CI:1.12-3.97,
P=0.019) and with mortality (HR=13.87, 95% CI:1.56-123.045, P= 0.018) even after
adjustments. Meeting energy recommendations (ER) reduced the chances of
hospitalization by 59% (HR=0.41 95% CI:0.21-0.79, P=0.008) and mortality was reduced
by 81% (HR=0.19, 95% CI:0.03-0.98, P=0.049), after adjustment. Kaplan-Meier curves
for SGA showed that well-nourished participants lived longer (Log Rank test P=0.002)
and had less hospitalizations than those moderate-to-severe malnourished (Log Rank test
P=0.007). Kaplan-Meier curves for MIS £ 5 showed that well- nourished participants,
lived longer and had less hospitalizations than those with MIS>5 (Log Rank test
P=0.033). Kaplan-Meier for energy intake showed that participants who met KDOQI
recommendations for energy intake survived longer (Log Rank test P=0.018) and had less
hospitalizations (Log Rank test P=0.005) than participants who did not meet them.
Meeting or not protein recommendations did not achieve significance (P=0.35). Albumin
was directly correlated with DEI (r=0.533, P<0.001) and DPI (r=0.369, P=0.001), and
MIS was inversely correlated with DEI (r=-0.495, P<0.001) and DPI (r=-0.471,
P<0.001). SGA was inversely correlated with DEI (r=-0.687, P<0.001) and DPI (r=-
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0.525, P<0.001) and BMI was directly correlated DEI (r=0.300, P=0.04) and DPI
(r=0.221, P=0.027).
Conclusion: Our findings support that MIS and energy intake are strong independent
predictors for hospitalization and mortality. Being well-nourished and meeting KDOQI
energy recommendations reduces the risk for mortality and hospitalization among
hemodialysis patients.

Introduction
Malnutrition is exceedingly prevalent in hemodialysis (HD) patients, ranging
from 16% to 62% depending on method being used to assess the nutritional status.1 There
is a growing evidence that diet is a significant risk factor for morbidity and mortality in
this population.2-4 Conversely, measures of good nutritional status, such as high Body
Mass Index (BMI) in combination with high muscle mass, are associated with increased
survival.5,6 In addition, nutritional competence increases resilience to adverse events,
such as hospitalization, in HD patients.7
In 2011, The International Society of Renal Nutrition and Metabolism (ISRNM)
coined the term protein-energy wasting (PEW) to the syndrome characterized by the loss
of body protein mass and fuel reserves in patients with CKD and ESRD in dialysis.8 The
ISRNM developed an objective criteria to incorporate all the different aspects of
malnutrition and other metabolic and/or nutritional derangements, such as inflammation,
and facilitated the timely and sensible diagnosis of PEW in this population vulnerable to
malnutrition.8
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Lack of appetite, anorexia, decreased intake, and lean body mass losses are very
common among hemodialysis patients. Each one of these signs, individually and in
combination, can be causally linked to the development of PEW syndrome.9 To prevent
the syndrome from happening, the National Kidney Foundation Kidney Disease
Outcomes Quality Initiative (KDOQI)10 and the European Best Practice guidelines11
established dietary recommendations for energy around 30 to 35 kcal/kg of calories and
for protein intake around 1.2 g/kg per day, of which at least 50% of protein should come
from foods containing high biological value protein.
The complexity of PEW and its significant impact on morbidity and mortality has
been widely recognized in HD patients.12 Among the most important determinants of
PEW in the context of renal disease, without any hesitation, are inadequate intakes of
protein and energy; however, it remains unclear which aspects of the PEW are a direct
cause of the poor renal outcomes, or if they are merely surrogate markers of other clinical
conditions.13 Early and sensitive detection of PEW through the continuous monitoring of
the nutritional status, followed by a prompt development of nutritional interventions,
when needed, is pivotal in improving clinical outcomes in hemodialysis patients.14
This study aims to assess the nutritional status of HD patients using the subjective
global assessment (SGA), malnutrition-inflammation score (MIS), and participants’
dietary energy and protein intakes and to examine the relationship of these variables with
hospitalization and mortality over one year.
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Methods

Study design and population
This is a 12-month prospective, single center study to evaluate energy and protein
intake and nutritional status of hemodialysis patients using two different assessment
tools. The outcomes and endpoints of this study are hospitalization, mortality and kidney
transplant. The study was approved by the Florida International University Institutional
Review Board (IRB# 17-0198-CR01). Seventy-seven participants were enrolled in the
study from May 2016 to Jun 2017 and informed consent was obtained. The inclusion
criteria were to be 19 years of age or older, receiving hemodialysis three times per week
for at least three months (maintenance hemodialysis) and being medically stable without
the reported existence of any acute infection. Patients were excluded if they were
receiving nutritional support via intradialytic parenteral nutrition or artificial feedings via
enteral nutrition, had a diagnosis of dementia or any other medical condition that could
interfere with completing the nutritional questionnaire, or if they refuse to participate or
comply with the study activities.

Demographic and biochemical data
Demographic data and biochemical parameters of interest were collected from
clinical charts and through interviews with the patients during the period of the study.
The demographic data collected included gender, age, ethnicity, hemodialysis start date,
baseline BMI and diagnosis of diabetes mellitus (DM). The biochemical data of interest

78

that were collected from medical documentation were serum albumin, total iron binding
capacity and dialysis adequacy (Kt/V).

Subjective Global Assessment (SGA)15
Nutritional status was determined at baseline, six month and 12 months using the
7-point SGA scale consisting of 2 categories: medical history and physical examination.
The medical history component included changes in weight, dietary intake,
gastrointestinal impairments, overall functional capacity, and data on disease and other
comorbidities. The physical examination section was estimated by identifying visible
signs of muscle wasting, loss of subcutaneous fat, and the presence of edema. The
registered dietitian assigned to this facility and who is responsible for the nutrition
management of these participants, rated each item using a scale from 1 to 7 and decided
the total SGA score. Based on the total SGA score, the patients were further categorized
into 3 groups as follows: Well-nourished SGA-A (score 6–7), moderate malnourished
SGA-B (score 3–5) and severely malnourished SGA-C (score 1– 2).

Malnutrition Inflammation Score (MIS)16
MIS was also determined at baseline, six month and 12 months. MIS, described
elsewhere,16 has 10 components (weight change, dietary intake, gastrointestinal
symptoms, functional capacity, comorbidity, subcutaneous fat, muscle wasting, BMI,
serum albumin level, and total iron-binding capacity) and each has four levels of severity,
from 0 (normal) to 3 (very severe). The sum of all composite scores of 10 MIS
components ranges from 0 to 30, denoting the increased severity of malnutrition and
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inflammation. The higher the MIS score, the worse the nutritional status is. MIS >5 was
set as the cut-off value to start indicating an abnormal nutritional status and the
concomitant presence of malnutrition and inflammation.17

Assessment of dietary intake and its compliance to current dietary
recommendations
During their routine visit for dialysis, all HD patients receive specific and
individualized dietary counseling together with menus examples, strategies and advices
based on Clinical Practice Guidelines for Nutrition in Chronic Renal Failure established
through the Kidney Disease Outcomes Quality Initiative (KDOQI).10 To conduct this
study, we assessed the dietary intake of the enrolled participants by using three 24-hour
diet recalls, taken during dialysis and non-dialysis days. The daily dietary intake was
calculated to represent the average of the three 24-hour diet recall and by using a
database from NutriBase 1986-2019 version 11.64 by CyberSoft, Inc. Participants’
dietary protein intake (DPI) and dietary energy intake (DEI) were compared to current
KDOQI guidelines (~1.2 g/kg protein; 30 to 35 kcal/kg of calories per day)

Endpoints: Hospitalization, mortality and transplants
Hospitalization was defined as any hospital visit considered as a full admission.
The occurrence of all hospitalization events was verified over 12 months, it included
diagnosis and cause for hospitalization. Kidney transplants and all deaths were recorded
during the period of the study.
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Statistical analysis
The main outcomes of interest in the present study were hospitalization and death.
For these outcomes, we reported absolute and relative frequencies, mean, standard
deviation, median, assuming data normality. For the inferential statistics, normal data
distribution was determined using the Kolmogorov-Smirnov test and the equality of
variances was confirmed using Levene's test. The comparisons between groups were
performed using unpaired Student-t test for normally distributed variables and the MannWhitney test for non-normally distributed variables as deemed appropriated. Categorical
variables were described using proportions and were analyzed by the chi-square test.
Odds ratios and 95% confidence intervals were calculated. Pearson and Spearman
correlations were used for bivariate analysis. Survival and hospitalization (time to first
hospitalization) curves were estimated by Kaplan-Meier analysis and compared using the
log-rank test. Cox proportional hazard model analyses were used to evaluate independent
predictors of hospitalizations and survival. The hazard ratios were obtained from Cox
regression analysis. The level of statistical significance was set at P<0.05. All statistical
tests were performed with SPSS version 20 software (IBM Corp., Armonk, NY, USA).

Results
Demographics participant’s characteristics
Fifty-five men and 22 women participated in this study; their mean age was 63.2
± 15.7 years. Their average time receiving dialysis was 6.2 ± 4.2 years and 58.4% of the
patients had a DM diagnosis in their medical chart; 18.2% were Hispanics, 39% were
Black, 31.2% were Whites and 11.7% were West Indians. During the 12-month study,
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63.6% participants had at least one hospital admission, 6 participants (7.8%) had a kidney
transplant, one participant (1.2%) dropped out of the study (transferred to another dialysis
center). A total of 13% (10/77) died, and all death-related causes were from
cardiovascular disease.

Subjective Global Assessment
Fifty-five percent (42/77) of participants were classified by their SGA year
average score as well-nourished (SGA-A), 36% (28/77) were moderate malnourished
(SGA-B) and 9% (7/77) were severe malnourished (SGA-C). Since the number of
severely malnourished participants were only 7, thus, too small to be analyzed separately,
a decision was made to collapse (SGA-B and SGA-C ) into only one group. The final
two groups were comprised of 55% well-nourished (SGA-A) and 45% moderate-tosevere malnourished (SGA-BC) (Table 1).

Malnutrition Inflammation Score
Forty-nine percent (38/77) participants had a year average score of MIS £ 5 who
were considered well- nourished and 50.6% (39/77) MIS >5, indicating the presence of
malnutrition-inflammation status and were considered moderate-to-severe malnourished
(Table 1).
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Diet intake and KDOQI guidelines compliance
The mean dietary energy intake (DEI) was 1867.3 ± SD 367.9 kcal/kg/day, and
the mean dietary protein (DPI) was 80.0 ± 15.8 g/kg/day. When DEI was compared with
DPI and KDOQI guidelines (30-35kcal/kg; 1.2 g/kg daily); only 53% (41/77) of the
participants met energy recommendations (ER) and 45% (35/77) did not.

Hospitalization and mortality analysis
Table 2 shows a comparison of hospitalized versus not hospitalized participants
and survivors versus non survivors. In this univariate analysis, survivors had greater SGA
score than those who died (5.49 ± 1.36 vs. 3.0 ± 1.76; P= 0.01) and lower MIS score
(6.12±2.9 vs. 10.21±3.91; P<0.00). Both scores indicated that patients that survived had a
better average nutritional status during the study period.
When comparing not hospitalized with hospitalized participants, we found that
BMI was higher in those with non-registered hospitalization (29.11 ± 5.44 vs 26.22 ±
5.34; P=0.02), had greater SGA score (5.67 ± 1.44 vs. 4.81 ± 1.69; P=0.04) and lower
MIS score (5.25 ± 2.07 vs. 7.25 ± 3.69; P=0.01). These finding, as the previous ones,
indicated that patients who exhibited better average nutritional status did not have any
admission to the hospital in the last12 months.
The effect of nutritional status measured by SGA on outcomes was further
analyzed in Table 3, which shows multivariate Cox regression models analyzing the
relationship between SGA (year-average) and hospitalizations and mortality. In this
analysis, we found that participants who were moderate to malnourished, as estimated by
SGA BC, had higher probability of death (HR=12.09, 95% CI=1.53-95.4, P=0.018).
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However, this relationship lost significance after adjusting for age, gender, ethnicity and
years in dialysis (P=0.067). SGA BC was associated with hospitalization and this
relationship remained significant after adjustments (HR=2.67, 95% CI:1.29-5.10,
P=0.003) (Table 3). This indicates that participants with moderate-to-severe malnutrition
have a 2.67 hazard risk for having at least one hospitalization event.
The effect of the nutritional status measured by MIS on outcomes was further
analyzed in Table 4, which shows the multivariate Cox regression models that analyzed
the association of MIS (year-average) with mortality and hospitalizations. These analyses
show that the mortality of HD patients was directly associated with MIS >5. After
adjusting for age, gender, ethnicity and years in dialysis (HR=13.87 95% CI:1.56-123.04,
P= 0.018). Similarly, hospitalization was associated with MIS>5 (HR=2.11, 95%
CI:1.12-3.97, P=0.019) even after adjustments (Table 4), which indicated that
participants diagnosed with Malnutrition-Inflammation Status, determined by the cut-off
value of greater than 5 had an increased hazard risk for both hospitalizations and
mortality.
The effect of meeting KDOQI energy recommendations on outcomes was further
analyzed. Table 5 shows multivariate Cox regression models that analyzed the effect of
meeting KDOQI energy recommendations and its association with hospitalization and
mortality. This analysis shows that meeting the energy recommendations (ER) reduces
the chances of hospitalization by 59% after adjusting for age, gender, ethnicity, albumin,
diabetes and years in dialysis (HR=0.41 95% CI:0.21-0.79, P=0.008). Similarly, mortality
of HD patients was reduced by 81% in those who met ER after adjusting for age, gender,
ethnicity albumin, diabetes and years in dialysis (HR=0.19 95%CI:0.03-0.98, P= 0.049)
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(Table 4). These results suggest that meeting recommendation for energy lowers the
possibility of hospitalization and mortality.

Kaplan Meier curves for hospitalizations and mortality
Kaplan-Meier survival curve for SGA-year average is shown in Figure A,
indicating that well-nourished participants (SGA-A) lived longer than participants who
were moderate-to severe malnourished (SGA-BC) during the study follow-up (Log Rank
test, P=0.002). Kaplan-Meier curve for hospitalization is shown in Figure B, indicating
that well-nourished participants (SGA-A) had lower hospitalization rate than participants
who were moderate-to severe malnourished (SGA-BC) during the study follow-up (Log
Rank test, P=0.007).
The Kaplan-Meier survival curve for MIS-year average (Figure C) showed that
participants with a MIS £ 5 classified as well- nourished, lived longer than participants
with MIS>5 who were classified as moderate-to severe malnourished (Log Rank test,
P=0.007) and Kaplan-Meier curve for hospitalization (Figure D) showed that MIS £ 5
had less hospitalizations that participants with MIS>5 (Log Rank test P=0.033),
indicating that having a good nutritional status determined by MIS ≤ 5 protected against
both hospitalization and mortality.
The Kaplan-Meier survival curve for energy intake is shown in Figure E;
participants who did not meet KDOQI recommendations for energy intake died sooner
than participants who did (Log Rank test P=0.018). The Kaplan-Meier curve for
hospitalization and energy intake shown in Figure F, demonstrated that participants who
did not meet KDOQI recommendations for energy intake had more hospitalizations than
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participants who met recommendations (Log Rank test P=0.005). However, meeting
KDOQI protein recommendations did not have any significant impact on hospitalization
and mortality (P=0.35).
Correlation between intake and nutritional status
Pearson correlations exhibited a strong direct correlation between DEI and DPI
(r=0.59, P<0.001). Albumin was directly correlated with DEI (r=0.533, P<0.001) and
DPI (r=0.369, P=0.001), and MIS was inversely correlated with DEI (r=-0.495, P<0.001)
and DPI (r=-0.471, P<0.001). SGA was inversely correlated with DEI (r=-0.687,
P<0.001) and DPI r=-0.525, P<0.001) and BMI was directly correlation DEI (r=0.300,
P=0.04) and DPI (r=0.221, P=0.027).

Discussion
To examine the presence of PEW and its impact on HD patient outcomes, a
variety of clinical and biochemical parameters have been successfully used, including
BMI,18 muscle mass,19 nPCR,20 dietary protein and energy intakes,21 serum albumin or
prealbumin levels,22 and more complex compositive scores such as SGA15 and MIS;16
however, no single tool or parameter could definitively diagnose PEW effectively. Prior
studies have reported a wide range of patients diagnosed with malnutrition. The
differences in ranges may be attributed to the characteristics of the study population, and
the variety of tools, assessment methods, and diagnosis criteria.1
In our cohort, MIS was more sensitive than SGA to detect the presence of PEW
and was a better predictor for hospitalization and mortality. In agreement with our
findings, other authors have reported that PEW prevalence using SGA was lower than
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PEW detected by MIS.23 Among the reasons for this discrepancy may be that MIS tends
to report a larger proportion of patients with a PEW diagnosis by considering serum
albumin levels and total iron binding capacity as part of its total score components. These
two biomarkers have a scale score, and both are strongly related to nutritional status and
inflammation.1,24 Another potential reason underlying these findings is the current lack
of a MIS gold-standard cut-off value for PEW diagnosis.1 In our study, we selected a
conservative MIS cutoff (MIS> 5) based on the prediction of mortality by a previous
review of articles.17 Other authors have used this same cut-off point for the diagnosis of
PEW in peritoneal dialysis patients, and compared its usefulness with other nutritional
tools;18 however, this might not be necessarily the best cut-off value for diagnosing PEW.
Also, in our study the results of the 7-point SGA were dichotomized as either wellnourished or moderate to severe malnourished for the analysis. As patients may be at
different stages of PEW based on the ratings of the scoring tools, in our study using these
cutoff points may affect the final results of this study. Therefore, future studies
determining the appropriate cut-off points for the scoring tools may further strengthen the
predicting value of the 7-point SGA and the MIS score for adverse outcomes and for
identifying the risk of developing PEW in patients receiving dialysis.
Based on our results, MIS, at the cut-off point of less or equal than 5, was a better
predictor of mortality than SGA, which lost significance after adjustment for other related
variables. Our results showed that both, MIS and SGA, were good predictors of
hospitalizations and mortality. Numerous prior studies have demonstrated that SGA is a
significant independent predictor of mortality in patients undergoing hemodialysis,3,4 and
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MIS, which was developed specifically for dialysis patients, has been considered a good
predictor of morbidity and mortality.16,17,26
By determining the average participant’s DPI and DEI, and whether they met
current KDOQI recommendations for protein and energy intake, we found that, despite
advice from their dietitians, nurses, doctors, and other health professionals, to promote
adequate intake among participants, a large proportion of them did not meet KDOQI for
energy and protein recommendations. In our cohort, approximately half (53%) met
KDOQI energy recommendations, while 55% met protein recommendations and only
21% met both energy and protein recommendations. These results are supported by
previous reports of DEI and DPI in dialysis patients that clearly demonstrated that the
majority of dialysis patients do not meet current KDOQI recommendations, which may in
turn increase their risk of PEW and ultimately increase morbidity and mortality in this
population.21,23 In agreement with our findings, Araujo et al.21 reported that inadequate
protein and energy intake was associated with worse survival in a single center study and
Antunes et al.23 also emphasized the importance of protein intake on survival in chronic
dialysis patients.
In our study, meeting dietary energy recommendations was a better predictor for
hospitalizations and mortality than meeting protein recommendations. Our results on
energy intake are supported by findings reported recently by Kang et al.,25 who found that
energy intake < 25 kcal/kg and MIS >5 were associated with 10-year mortality in HD
patients. However, our results on the relationships of protein intake and the disease
outcomes contradicted what has been reported about low protein dietary intake and its
relationship with increased death rates previously reported by Kalantar-Zadeh et al.,24
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who demonstrated that protein intake measured indirectly by means of nPCR was
associated with outcomes. In our study, the average participant’s protein intake was
assessed as an average of three 24-hour diet recalls taken on dialysis and not dialysis days
by a trained dietitian, which reflects with more accuracy the average patient’s intake and
the customary diet. Contrasting with the report by Kalantar-Zadeh et al.,24 reports by
other researchers have shown that greater protein intake >1.4g/kg/day are associated with
increased phosphorus levels, which ultimately can be related to mortality. Based on these
results, researches proposed the impact of adequate energy intake is more important for
disease outcomes than protein intake, and that excessive protein intake should be
avoided, since it appears to be deleterious.14
Additionally, to the above discussed discrepancies about the impact of protein
intake on patient outcomes, there are other conditions that could explain our results; most
of our participants received protein supplements at certain point during the study
according to their albumin levels in plasma, and they were followed using the latest
nutritional recommendations for the management of hypoalbuminemia. However, the
impact of protein supplements on outcomes are still not known and controlled studies are
needed to elucidate their effect.28
This study has numerous limitations that should be considered in interpreting its
findings. First, the sample size was small and only included subjects from a single
dialysis center, therefore its generalizability to other populations is limited. In addition,
given that it is an observational study, it is difficult to separate the complex interactions
of variables. In this study, we examined the 12-month average scores of SGA and MIS
and their predictive impact on hospitalization and mortality; however, we did not
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examine changes in nutritional status and the impact of those changes in hospitalizations
and mortality. Even though our study confirmed that inadequate energy and protein
intakes are important determinants for PEW, and that meeting energy recommendations
is significantly linked to adverse outcomes, due to the complex and multifactorial
characteristics of PEW syndrome, we cannot rule out that other disease-related factors
may directly or indirectly influence energy and protein intakes, so their deficiencies may
be the consequence and not the cause of the adverse outcomes.

Conclusions
Our findings support an association of the nutrition-inflammation status, detected
by sensitive indices, and energy intake with reduced hospitalization and mortality risks
among hemodialysis patients. Meeting energy recommendations has a positive impact on
preventing hospitalization and decreasing mortality rates. This study provides
observational evidence for early detection of patients at risk of PEW and initiating timely
nutrition interventions that aim to improve nutrition-inflammation status and promote
adequate protein and energy intake. Further controlled studies with adequate sample size
should evaluate other nutrients that may modulate malnutrition in these patients.
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Table 1: Classification of participants in well-nourished and moderate-to-severe
malnourished (year average) by nutrition assessment tools
Nutrition assessment tools
Subjective Global
Assessment
Malnutrition Inflammation
Score

Well-nourished
SGA-A

Moderate-to-severe malnourished
SGA-BC

55% (42/77)

45% (35/77)

MIS £ 5

MIS>5

49% (38/77)

50.6% (39/77)

N=77, SGA-A= participants classified as well nourished by Subjective Global Assessment, SGA-BC= participants
classified as moderate-to-severe malnourished by Subjective Global Assessment, MIS>5= participants classified as
moderate-to-severe malnourished by Malnutrition Inflammation Score greater than 5 (year average)

Table 2: Table of characteristic comparing not hospitalized versus hospitalized and
survivors versus non-survivors
Variable

NotHospitalized
N=28
63.21± 14.79

Hospitalized
N=49
63.3 ± 16.46

Female
Diabetes
Years in
dialysis
BMI

10.14%
18.2%
7.15 ± 4.83

Albumin
KtV
SGA
MIS

Age

Pvalue*

0.98

NonSurvivors
N=67
N=10
62.7±17.23 67.1±12.28

14%
40.3%
5.65 ± 3.73

0.67
0.18
0.13

26.0%
2.6%
48.1%
10.4%
6.30 ± 4.28 5.53 ±3.74

0.41
0.12
0.59

29.11 ± 5.44

26.22 ± 5.34

0.02

25.36 ±4.92

0.24

3.70 ± 0.30
1.49 ± 0.20
5.67 ± 1.44
5.25 ± 2.07

3.86 ± 0.30
1.50 ± 0.18
4.81 ± 1.69
7.25 ± 3.69

0.80
0.89
0.04
0.01

27.56 ±
5.58
3.52 ± 0.26
1.50±0.17
5.49±1.36
6.12±2.9

3.91±0.34
1.46±0.24
3.0±1.76
10.21±3.91

0.59
0.51
0.01
0.00

Pvalue*

*Student

Survivors

T test, statistically significant P<0.05
BMI=Body mass index, Kt/V=dialysis clearance, SGA=Subjective Global Assessment, MIS= Malnutrition
Inflammation Score
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0.14

Table 3: Multivariate Cox regression models analyzing SGA (year-average) for mortality
and hospitalizations

Covariate

Unadjusted
Hazard Ratio
95% CIa

P-value

Adjusted
Hazard Ratio
95% CIa

P-value

MORTALITY
Age
Gender
Ethnicity
Years-in-dialysis
KtV
Diabetes
Albumin
SGA BC

1.01(0.97-1.06)
1.64(0.35-7.76)
1.35(0.67-2.69)
0.94(0.80-1.12)
0.24(0.01-8.54)
3.08(0.65-15.51)
2.22(0.20-23.79)
12.09(1.53-95.49)

0.400
0.528
0.393
0.540
0.432
0.155
0.509
0.018

1.01(0.97-1.06)
1.64(0.35-7.76)
1.35(0.67-2.69)
0.94(0.80-1.12)
0.10(001-9.078)
3.08(0.65-15.51)
33.05(0.86-1264.69)
7.479(0.870-64.03)

0.977
0.338
0.617
0.068
0.317
0.414
0.060
0.067

0.98(0.96-1.00)
1.08(0.55-2.13)
1.06(0.76-1.52)
0.94(0.87-1.01)
1.75(0.32-9.64)
1.43(0.78-2.64)
1.82(0.49-6.71)
2.67(1.39-5.10)

0.168
0.811
0.674
0.133
0.516
0.245
0.366
0.003

HOSPITALIZATIONS
Age
Gender
Ethnicity
Years-in-dialysis
KtV
Diabetes
Albumin
SGA BC

0.99(0.98-1.01)
1.00(0.54-1.87)
1.16(0.84-1.69)
0.94(0.88-1.01)
1.17(0.25-5.32)
1.44(0.80-2.57)
1.16(0.38-3.56)
2.06(1.17-3.64)

0.851
0.977
0.355
0.131
0.838
0.218
0.787
0.012

aCI=

confident interval, statistically significant P<0.05
Kt/V=dialysis clearance, SGA BC= participants classified as moderate-to-severe malnourished by Subjective Global
Assessment tool (year average)
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Table 4: Multivariate Cox regression models analyzing MIS (year-average) for mortality
and hospitalizations

Covariate

Unadjusted
Hazard Ratio
95% CI*

P-value

Adjusted
Hazard Ratio
95% CI*

P-value

MORTALITY
Age
Gender
Ethnicity
Years-indialysis
KtV
Diabetes
Albumin
MIS>5

1.01(0.97-1.06)
1.64(0.35-7.76)
1.35(0.67-2.69)
0.94(0.80-1.12)

0.400
0.528
0.393
0.540

1.00(0.96-1.05)
1.27(0.49-11.06)
1.10(0.47-2.59)
0.94(0.77-1.14)

0.497
0.780
0.773
0.797

0.24(0.01-8.54)
3.08(0.65-14.51)
2.22(0.01-8.54)
9.91(1.25-78.29)

0.434
0.155
0.509
0.030

0.31(0.00-31.44)
2.89(0.49-16.94)
15.63(0.451-540.84)
13.87(1.56-123.05)

0.622
0.239
0.128
0.018

HOSPITALIZATIONS
Age
Gender
Ethnicity
Years-indialysis
KtV
Diabetes
Albumin
MIS>5

0.99(0.98-1.01)
1.00(0.54-1.87)
1.16(0.84-1.69)
0.94(0.88-1.01)

0.851
0.977
0.355
0.131

0.98(0.97-1.00)
1.13(0.60-2.12)
1.02(0.72-1.45)
0.93(0.85-1.00)

0.253
0.699
0.876
0.079

1.17(0.25-5.32)
2.52(0.42-14.87)
1.16(0.38-3.56)
1.79(1.01-3.17)

0.839
0.306
0.787
0.045

2.52(0.42-6.71)
1.45(0.78-2.68)
1.71(0.43-6,71)
2.11(1.12-3.97)

0.036
0.229
0.442
0.019

*CI=

confident interval, statistically significant P<0.05
dialysis clearance, MIS=Malnutrition Inflammation Score, MIS>5= participants classified as moderate-tosevere malnourished by MIS score greater than 5 (year average)
1Kt/V=
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Table 5: Multivariate Cox regression models analyzing participants that met
KDOQI/energy recommendations for mortality and hospitalizations

Covariate

Unadjusted
Hazard Ratio
95% CI*

P-value

Adjusted
Hazard Ratio
95% CI*

P-value

1.00(0.95-1.04)
1.47(0.26-8.31)
1.13(0.54-2.26)
0.98(0.81-1.20)
0.16(0.002-15.40)
2.20(0.43-11.21)
3.47(0.34-34.93)
0.19(0.03-0.98)

0.992
0.662
0.745
0.915
0.439
0.341
0.290
0.049

MORTALITY
Age
Gender
Ethnicity
Years-in-dialysis
KtV
Diabetes
Albumin
Met ER (yes)

1.01(0.97-1.06)
1.64(0.35-7.76)
1.35(0.67-2.69)
0.94(0.80-1.12)
0.24(0.01-8.54)
3.08(0.65-15.51)
2.22(0.20-23.79)
0.19(0.04-0.91)

0.400
0.528
0.393
0.540
0.434
0.155
0.059
0.038

HOSPITALIZATIONS
Age
Gender
Ethnicity
Years-in-dialysis
KtV
Diabetes
Albumin
Met ER(yes)

0.99(0.98-1.01)
1.00(0.54-1.87)
1.16(0.84-1.69)
094(0.88-1.01)
1.17(0.25-5.32)
1.44(0.80-2.57)
1.16(0.38-3.56)
0.46(0.26-0.82)

0.851
0.977
0.355
0.131
0.838
0.218
0.787
0.008

0.98(0.96-1.00)
1.07(0.53-2.14)
0.97(0.69-1.37)
0.93(0.86-101)
1.56(0.44-5.48)
1.21(0.65-2.25)
1.56(0.27-9.25)
0.41(0.21-0.79)

*CI= confident interval, statistically significant P<0.05
Kt/V= dialysis clearance, Met ER (yes)= met KDOQI/energy recommendations
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0.131
0.850
0.891
0.099
0.482
0.537
0.484
0.008

Table 6: Multivariate Cox regression models analyzing participants that met
KDOQI/protein recommendations for mortality and hospitalizations
Covariate

Unadjusted HR
95% CI*

P-value

Adjusted HR
95% CI*

P-value

MORTALITY

Age
Sex
Ethnicity
Years-in-dialysis
Diabetes
Albumina
KtV
MET PR

1.01(0.97-1.06)
1.64(0.35-7.76)
1.35(0.67-2.69)
0.94(0.80-1.12)
3.08(0.65-14.51)
2.22(0.20-23.79)
0.24(0.01-8.54)
3.20(0.90-11.37)

0.400
0.528
0.393
0.540
0.155
0.509
0.434
0.068

1.00(0.96-1.05)
1.53(0.28-8.30)
1.03(0.48-2.21)
0.94(0.76-1.17)
3.00(0.61-14.67)
5.35(0.42-68.03)
0.37(0.00-23.37)
0.15(0.01-1.27)

0.738
0.618
0.929
0.627
0.174
0.196
0.645
0.082

HOSPITALIZATIONS

Age
Sex
Ethnicity
Years-in-dialysis
Diabetes
Albumina
KtV
MET PR

0.99(0.98-1.01)
1.00(0.54-1.87)
1.16(0.84-1.59)
0.94(0.88-1.01)
1.44(0.80-2.57)
1.16(0.38-3.56)
1.17(0.25-5.32)
1.41(0.78-2.52)

0.851
0.977
0.355
0.131
0.218
0.787
0.838
0.247

0.99(0.97-1.01)
0.96(0.47-1.94)
1.11(0.80-1.56)
0.93(0.86-1.01)
1.50(0.82-2.74)
1.14(0.31-4.25)
1.70(0.29-10.02)
1.07(0.56-2.05)

*CI= confident interval, statistically significant P<0.05
Kt/V= dialysis clearance, Met PR (yes)= met KDOQI/protein recommendations
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0.399
0.915
0.515
0.122
0.182
0.837
0.554
0.827

Figure A: Kaplan-Meier curve for Mortality and SGA (year average)

Figure B: Kaplan-Meier curve for Hospitalization and SGA (year average)
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Figure C: Kaplan-Meier curve for Mortality and MIS (year average)

Figure D: Kaplan-Meier curve for Hospitalization and MIS (year average)
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Figure E: Kaplan-Meier curve for Mortality and energy intake

Figure F: Kaplan-Meier curve for Hospitalization and energy intake

Fig A showed that participants in SGA-A group lived longer than participants in SGA-BC (Log rank test P=0.002)
Fig B showed that SGA-A group had lower hospitalization rate than group SGA-BC (Log rank test P=0.007)
Fig C showed that patients in MIS £ 5 group longer than participants in MIS > 5 group (Log rank test P=0.007)
Fig D showed that participants in the group MIS £ 5 had less hospitalizations than participants in MIS >5 group (Log
rank test P=0.033)
Fig E showed that patients that met energy recommendations (MET ER) lived longer that patients that did not(Not
MET ER) (log rank test, P=0.018)
Fig F showed that patients that met energy recommendations (MET ER) had less hospitalizations that patients that did
not (Not MET ER)(Log rank test P=0.005)
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CHAPTER V: DIET QUALITY AS A PREDICTOR OF POOR OUTCOMES IN
HEMODIALYSIS PATIENTS AND ITS RELATIONSHIP WITH
INFLAMMATION
Abstract
Objective: Despite major advances in dialysis technology, protocols and
pharmacological treatment, hospitalization and mortality rates are highly prevalent
among hemodialysis (HD) patients. Multiple diet restrictions placed upon HD patients
add to the very common problem of poor diet, inadequate intake and poor dialysis
outcomes. This study evaluates the association of the hemodialysis patient’s diet quality
index with hospitalization and mortality, and explores the relationship between diet
quality and inflammation.
Design: This is a 12-month prospective cohort study that recruited 77 participants from
May to Jun 2017.
Results: Fifty-five men and 22 women participated in this study; the mean age for the
cohort was 63.2 ± 15.7 years. Their average time receiving dialysis was 6.2 ± 4.2 years
and 58.4% of the patients were diagnosed with Type 2 diabetes mellitus; 18.2% were
Hispanics, 39% were Black, 31.2% were Whites and 11.7% were West Indians. In 12
months, 63.6% of participants had at least one hospitalization, 6 participants (7.8%)
underwent kidney transplant and 10 (13%) died of cardiovascular diseases. The mean
hospitalization per patient in 12 months (PPY ± SD) was 1.1 ± 0.2. Survivors had a
significant greater energy intake when compared with non-survivors; DEI (1917 kcal ±
400 vs. 1615 ± 321, P= 0.026) significant greater cereal-fiber intake (11.5 g ± 4.4 vs 7.4
± 4.4, P=0.007); and significant greater fruit intake (servings/day) 2.38 ± 0.99 vs 1.5 ±
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0.84, P=0.009. Participants who were not hospitalized consumed more fruit servings (2.6
± 1.06 vs. 2.08 ± 0.95, P=0.029) than hospitalized. The intake of two or more fruit
servings per day was associated lowered mortality risk by 75% (HR=0.246, 95%CI:
0.069- 0.880, P=0.031); and the intake of at least 7 grams of cereal fiber a day, lowered
mortality risk by 81% (HR= 0.187; 95.0% CI:0.050-0.693, P=0.012). Participants with
the lowest level of inflammation (NLR<1.75) had a statistically significant greater AHEI
score and cereal-fiber (g/day) than the rest (P<0.005).
Conclusion: Hemodialysis patients should be encouraged to use various food sources to
meet their energy and protein requirements, as well as to satisfy at least two portions of
fruits and 7 grams of cereal fiber per day to prevent cardiovascular mortality. The current
MNT for dialysis should be re-considered and be liberalized to allow a more relaxing
approach that facilitates greater intake and ultimately improves outcomes.

Introduction
Despite major advances in dialysis technology, protocols and pharmacological
treatments, ESRD patients still are experiencing a high hospitalization and mortality
rate.1 There are different factors underlying mortality in dialysis patients but the major
cause of death is cardiovascular disease, which accounts for approximately 50% of
deaths.2 Other causes of death are mainly from infections and withdrawal from dialysis.2,3
While the consumption of food and fluids is a vital activity for species’ survival, in CKD
and ESRD patients as GFR decreases, a profound decline in energy and protein intakes
are manifested.4 The prevalence of anorexia has been reported between 30-55% in
ESRD.5 Anorexia, itself, is an important independent cause of adverse outcomes; it has
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been associated with four times higher risk of death in this population.6 To make things
even worse, the standard renal diet, distinctive by its innumerable food and nutrient’s
restrictions, adds to the problem of poor diet, inadequate intake and malnutrition
prevalent among ESRD patients.7
The study of dietary patterns and diet quality indexes have attracted greater
attention in the last decades.8 The concept of “diet quality” can be very broad, but there
is a general consensus that a high-quality diet is a balanced diet that meets the individual
nutritional needs and guarantees good health.8 Many new methods and approaches have
recently emerged as reliable ways of determining the adequacy of dietary intake
compared to specific guidelines.8-12,16-21
Dietary quality indexes have many potential applications in the field of health
assessment or disease-risk assessment.11 They have proven to be practical and reliable to
investigate the relationship between diet and health outcomes.10-12 Particularly, quality
indexes are an easily way to assess the risk for the development of chronic diseases such
as cardiovascular disease.12
An eating index is a mathematical algorithm that combines epidemiological
observations about food-related concepts, in order to quantify and assign a score to the
total quality of the overall diet and or eating patterns.11
Healthy dietary patterns have shown to be associated with lower mortality in
people with ESRD and HD patients.13 However, dietary intake in hemodialysis patients
does not reflect a heart-healthy diet,14 on the contrary, it has been reported that, in
average, a dialysis patient has low consumption of fruits and vegetables and whole
grains, which have been associated with cardiovascular disease risk.15 All-cause mortality
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in this population have been shown to a have significant association with inadequate
intake of fruits and vegetables.16 Insufficient calorie intake has been reported as the
single most limiting factor for a better diet quality and adequate energy intake improves
outcomes in patients living with dialysis.17
The interrelation of diet quality with inflammation status in hemodialysis patients
is not clear and the literature is contradictory.18,19 There is no specific diet quality index
that has been found to better predict morbidity and mortality, specifically in patients
treated with hemodialysis.8,9,15,20 Adequate nutritional intake and dietary eating patterns,
including the quality of the diet may have prognostic implications for patients outcomes
through mechanisms independent of nutritional status, which warrants further studies.
The assessment of the diet quality of hemodialysis patients can be a useful tool for the
development and application of new nutritional strategies aiming to make meaningful
changes in patient’s eating habits to improve their overall well-being.
To fill this gap in the literature, this study evaluated the association of the
hemodialysis patient’s diet quality index with hospitalization and mortality and explored
the relationship between diet quality and inflammation.

Methods:
Study design and population
This is a 12-month prospective, single center study to evaluate the diet quality
index of hemodialysis patients using the Alternative Healthy Eating Index (AHEI). The
outcomes and endpoints of this study are hospitalization and mortality. The study was
approved by the Florida International University Institutional Review Board (IRB).
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Seventy-seven participants were enrolled in the study from May 2016 to Jun 2017 and
informed consent was obtained. The inclusion criteria were as follows: participants were
19 years of age or older, received hemodialysis three times per week for at least three
months and were medically stable without acute infection. Patients were excluded if they
were receiving any type of nutrition support via intradialytic parenteral nutrition or al
nutrition, were suffering from dementia that interfered with completing the nutritional
questionnaires, or refused or were unwilling to enroll in the study.

Demographic and biochemical data
Clinical and demographic data were collected from clinical charts and through
ongoing interviews with the patients for 12 months. The demographic data included
gender, age, ethnicity, hemodialysis start date, body max index (BMI), and diagnosis of
diabetes mellitus (DM).

Assessment of dietary intake
During their hemodialysis treatments, all patients received specific dietary
counseling together with menus examples, strategies and advices based on KDOQI
Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.1 For the purpose of
this particular study, the average dietary intake of the enrolled participants were
calculated from three 24-hour diet recalls, obtained during dialysis and non-dialysis days
by a registered dietitian. The daily dietary intake was estimated by using a database from
NutriBase 1986-2019 version 11.64 by CyberSoft, Inc.
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Diet quality assessment
The diet quality was assessed by the Alternative Healthy Eating Index (AHEI)
originally developed by McCullough et al.21 using the information collected from the
average of the 24-hr recalls. The total AHEI score is based on the points assigned to each
food group, each contributed 0–10 points to the total, as described elsewhere;21 a score of
10 indicates that the recommendations were fully met, a score of 0 indicates the least
healthy dietary behavior and intermediate intakes were scored proportionately between 0
and 10, based on the dietitian’s judgement. The items included in the original version of
the AHEI score are as follows: the consumption of vegetables, fruits, nuts &soy protein,
all representing by servings per day. The white-to-red meat ratio and the cereal- fiber
(g/day). The indices also include different type of fats including trans fatty acids (% of
total energy), polyunsaturated -to -saturated fatty acid ratio, duration of vitamin use and
alcohol intake (servings/day). The rationale for including each component and the scoring
criteria are described elsewhere.21 The multivitamin component has not scaling score, it is
dichotomous variable that contributes to the total AHEI score to either 2.5 points (for
nonuse) or 7.5 points (for use). After all component scores are calculated and added up,
then the total AHEI score ranged from 2.5, which presents the worst diet quality to 87.5,
the best diet quality.
In our cohort, all participants were taking vitamins and mineral supplements,
according to their prescription. A 7.5-point score was ascribed to the entire cohort for
multivitamin use. None of the patients were drinking alcohol at the time that the 24-hour
recalls were obtained. For alcohol consumption, all patients were ascribed a score of zero,
corresponding to nonuse.
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Analysis of inflammation measured by Neutrophil-lymphocyte ratio (NLR) and its
relationship with diet quality
Neutrophil-to-lymphocyte ratio (NLR) has emerged as practical marker for
systemic inflammation in Chronic Kidney Disease (CKD) and ESRD.22 The ratio is
calculated by dividing neutrophil count by lymphocyte count, which makes it a costeffective, simple parameter that allows to easily assess the inflammatory status of a
subject.22,23It has shown a direct correlation with albumin levels and with C-reactive
protein in hemodialysis patients.23
For the analysis of the relationship between inflammation and diet, we measured
NLR at baseline and participants were grouped by their NLR value into quartiles for the
analysis and comparison of different levels of inflammation. quartile 1 (NLR ≤1.75),
quartile 2 (NLR 1.76-2.6), quartile 3 (NLR 2.7-3.9) and quartile 4 (NLR ≥4), which
represents the lowest to the highest level of inflammation.

Endpoints: Hospitalization and mortality
Hospitalization was defined as any hospital stay lasting one night or longer. The
occurrence of hospitalization was verified over 12 months, the data included type of
diagnosis for hospitalization, kidney transplant as well as death (all-cause mortality).

Statistical analysis
The final outcomes of interest in the present study were mortality and
hospitalization. Normal data distribution was confirmed by the Kolmogorov-Smirnov
test, the equality of variances was confirmed by Levene's test. Unpaired Student-t test,
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Mann-Whitney test were used as deemed appropriated for groups comparison.
Categorical variables were described using proportions and compared by chi-square test,
odds ratios and 95% confidence interval were calculated. Pearson and Spearman
correlations were used for bivariate analysis. To evaluate independent predictors of
survival we used Cox proportional hazard models. The hazard ratios were obtained from
Cox regression analysis. The level of statistical significance was P<0.05. All statistical
tests were performed with SPSS version 20 software (IBM Corp., Armonk, NY, USA).

Results
Demographics participant’s characteristics
Fifty-five men and 22 women participated in this study; the mean age for the
cohort was 63.2 ± SD15.7 years. Their average time receiving dialysis was 6.2 ± 4.2
years and 58.4% of the patients were diagnosed with Type 2 DM; 18.2% were Hispanics,
39% were Black, 31.2% were Whites and 11.7% were West Indians. In 12 months,
63.6% of participants had at least one hospitalization, 6 participants (7.8%) were
terminated due to kidney transplant, one participant (1.2%) was transferred to another
dialysis center, and 10 (13%) died of cardiovascular diseases. The mean hospitalization
per patient in 12 months (PPY ± SD) was 1.1 ± 0.2.

Diet intake assessment
Survivors had a significant greater energy intake when compared with nonsurvivors; DEI (1917 kcal ± 400 vs. 1615±321, P= 0.026) while protein intake between
survivors and non-survivors did not achieve statistical significance (81g ± 16 vs. 66±11,
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P=0.06). Survivor had also greater cereal-fiber intake (11.5 ± 4.4 vs 7.4 ± 4.4, P=0.007)
and greater fruit intake (2.38 ± 0.99 vs 1.5 ± 0.84, P=0.009). No statistically significant
differences were detected with the rest of the examined variables (Table 2).
When comparing patients who were not hospitalized with hospitalized patients,
differences in fruit intake was statistically significant (2.6 ± 1.06 vs. 2.08 ± 0.95,
P=0.029) (Table 2).

Multivariate cox regression analysis models for hospitalization and mortality
Variables that were significant in univariate analysis (cereal-fiber P=0.007; fruit
P=0.009, P=0.029) were further analyzed in a multivariate cox regression analysis for
hospitalization and mortality (Table 3 and 4).
Table 3 and Table 4 show a multivariate cox regression analysis models for
mortality and hospitalization using gender, age and diabetes as covariates. The intake of
two or more fruit portions per day reduced mortality risk by 75% (HR=0.246,
95%CI:0.069- 0.880, P=0.031); and the intake of at least 7 grams of cereal fiber a day,
decreased mortality risk by 81% (HR= 0.187; 95.0%CI:0.050-0.693, P=0.012); after
adjusting by age, gender and diabetes the relationships remained significant.

Diet quality-AHEI calculation
Table 5 shows the comparison of the AHEI between survivors and non-survivors;
not hospitalized and hospitalized. When survivors were compared with non-survivors, the
only statistically significant differences that were detected in this analysis were in the
cereal -fiber score (6.02 ± 2.2 vs. 4.4± 2.4; P=0.035) and fruit score (5.72 ± 2.6 vs. 3.4
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±2.4; P=0.010). The total score for AHEI and its individual components did not show
statistically significant differences neither for mortality nor hospitalization.

Analysis of inflammation measured by Neutrophil-lymphocyte ratio (NLR) and its
relationship with diet quality
Table 6 shows the comparison of the total AHEI score, sub-scores and diet
components by comparing participants grouped into NLR quartiles: quartile 1 (NLR £
1.75), quartile 2 (NLR 1.76-2.6), quartile 3 (NLR 2.7-3.9) and quartile 4 (NLR ≥4.0). In
this one-way ANOVA analysis, we detected statistically significant differences in cerealfiber (g) across the different quartiles of inflammation; quartile 1: 9.4±4.2, quartile 2:
13.4±3.1, quartile 3: 11.1±5.7, quartile 4: 10.2±4.5; P=0.04). Total AHEI and the rest of
the score and diet components did not achieve statistically significant differences among
inflammation quartiles.
In addition, to analyze the differences between the lowest level of inflammation
and the rest on diet quality and its components (NLR ≤ 1.75 vs NLR >1.75). In this
analysis, participants with the lowest level of inflammation had a statistically significant
greater AHEI, P= 0.046; cereal fiber score, P= 0.014 and cereal-fiber (g/day), P=0.008
than the rest (Table 7).
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Discussion
In the current study, we investigated the diet quality of participants receiving
hemodialysis therapy using the AHEI and examined its association with hospitalizations
that were registered during the period of the study (12 months) and mortality. We also
explored the association of diet quality and diet components with inflammation. The
following discussion interprets these findings in the context of the existing literature.
By comparing survivors with non-survivors, we found that patients who died had
lower energy intake (DEI:1615 kcal ±321 vs. 1917 ± 400, P=0.026), cereal-fiber (11.5 g
± 4.4 vs. 7.4 ± 4.4, P= 0.007), and fruit servings per day (1.5 ± 0.84 vs.2.38 ± 0.99,
P=0.009). When comparing hospitalized with not hospitalized patients, only the intake of
fruit (servings/day) was significant lower in the hospitalized participants (2.08 ± 0.95 vs.
2.60 ±1.06, P=0.029).
Analyzing AHEI and its components between survivors and non survivors,
hospitalized and not hospitalized patients; we found that consuming at least two fruit
servings per day, decreased mortality risk by 75% (HR=0.246; 95.0%,CI 0.069- 0.880,
P=0.031), and eating at least 7 grams of cereal fiber a day, decreased mortality risk by
81% (HR= 0.187; 95.0%, CI0.050-0.693, P=0.012); when adjusted by age, gender and
diabetes the relationships remained significant; however, neither AHEI total score not its
individual components’ scores had any significant effect on hospitalization.
Recent systematic reviews and meta-analyses stated that many dietary guidelines
agree that the daily fiber intake for the general population should be at least 20–35 g/day
to achieve optimal health.24 In the case of hemodialysis patients, the intake of fiber is far
below those recommendations.25,26 Dietary restrictions for potassium, phosphorus and the
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presence of malnutrition are the major contributions to this low intake of fiber among
CKD patients. Studies of the dietary intake have consistently demonstrated that fiber
intake is lower than the recommended for reducing the risk of cardiovascular disease in
this population.25
In our cohort, 90% of the participants reported a total fiber intake lower than
25g/day. Similarly, Koueiry et al.14 conducted a cross-sectional analysis of the diet of 70
hemodialysis patients using a food frequency questionnaire validated in dialysis patients.
In this analysis, the main outcome variable was dietary fiber intake, but the authors also
focus on energy and protein intake, soluble fiber and fats. Even tough, the analysis
included a small sample size, it is remarkable that only two participants had a fiber intake
of 25 g/day or above. This means that 97% of the entire cohort did not meet the current
recommendations for an optimal cardiovascular health.14
It is very well-known that the renal diet is one of the most difficult to teach and to
follow, and that it is very unpopular among patient with kidney disease. It consists of
multiple nutrient restrictions to guarantee the control within normal limits of nutritionrelated labs, including phosphorous, potassium and calcium. The emotional and
physiological burden of those restrictions may present an important contribution to the
reported poor intake and low diet quality seen in this population. The intake of many food
groups and nutrients, including fruits and fiber are found to be insufficient among dialysis
patients.26 Our results are also in agreement with what has been reported by Luis et
al.,27who after examining the diet of hemodialysis patients described that their diets were
potentially atherogenic, very low in fiber and high in saturated fat. The study conducted
by Wai et al.16 supports the idea about an atherogenic diet profile found in most dialysis
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patients. The authors found in this study that all-cause mortality had a significant
association with adequate intake of fruits and vegetables (HR: 0.35; 95% CI, 0.15-0.83)
in patients with CKD stage 3 or 4.
The rationale linking fruit intake and mortality was proposed by Bermejo et al.,28
who claimed that a high fruit intake is a vehicle for vitamin, minerals, phytochemicals
and antioxidants consumption, which may reduce homocysteine levels and improve
overall cardiovascular health.29 Previous research has discussed the physiological
advantages of dietary fiber in the context of renal disease. In these conditions, fiber can
bind with dietary phosphorous in the gut and be excreted in feces.30 High serum levels of
phosphorus have been associated with adverse outcomes in maintenance HD patients.31
In our analysis of the relationship between inflammation and diet quality, we
found that in our cohort, participants in the lowest quartile of inflammation had a better
diet quality (greater AHEI scores) and scored higher in cereal-fiber subcomponent when
compared to the rest of the patients. Our findings suggest a beneficial potential role of
cereal-fiber and overall quality of the diet in modulating inflammation and decreasing
mortality, which have been reported by previous researches.24,32,33
In an attempt to explain the association of high dietary fiber intake with decreased
inflammation, several mechanisms have been proposed.33-36 Dietary fiber may modulate
inflammation by lowering the absorption of dietary carbohydrates.34 High-fiber diets are
associated with higher plasma levels of functional substances produced by colonic
bacteria such as indoles, phenols, and amines. These functional substances are thought to
have a role in systemic inflammation.35 In addition to those effects, high-fiber diet
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decreases systemic concentrations of uremic toxins by potentially altering gut bacterial
metabolism.36
Unfortunately, current Medical Nutrition Therapy (MNT) for hemodialysis
patients dictates that patients shift their nutrition goals from standard dietary
recommendations to limit intake in many foods high in fiber including fruits, vegetables,
nuts, whole grains among many others. As a result of numerous restrictions, their diet
departs from what is considered a healthy, balanced and adequate diet,14, 15, 27,32 which
may further exacerbate health complications and facilitate the unset of comorbidities
associated with ESRD, including cardiovascular disease. 38

Limitations
The extrapolation of our findings and the potential practical applications to other
hemodialysis populations are limited by a small sample size of participants from only one
hemodialysis facility. Notwithstanding the validity of the aforementioned mechanisms of
actions, the long-term consequences of a low quality diet and the nutritional deficiencies
corresponding to low cereal-fiber and fruit intake remain unknow. Large scale
observational studies have not been conducted to determine outcomes associated with the
long-term individual deficiencies observed in renal diets, and clinical control trials
concerning supplementations are needed. In addition, our cut-off value for NLR was
similar to that used by others; however, studies are needed to answer which NLR cut-off
values are optimal and clinically meaningful.
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Conclusion
Hemodialysis patients should be encouraged to use various food sources to meet
their energy and protein requirements, as well as to satisfy at least two portions of fruits
and 7 grams of cereal fiber per day to prevent cardiovascular mortality. Considering the
socio-economic burden associated with HD treatment, efforts must be made to support a
better diet quality and to increase patient dietary choices. The current MNT for dialysis
should be re-considered and liberalized to allow a more relaxing and enjoyable approach
to eating that facilitates greater intake and ultimately improves outcomes.
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Table 1. Cohort’s demographics characteristics and 12 month-endpoints
Variable

Mean±SD

Age
Female
Years-in-dialysis
BMI
Diabetic

62.3 ± 12.7
28.6%
6.2 ± 4.2
27.2 ± 5.5
58.4%

Ethnicity
Hispanic
AA
Caucasian
West Indian

18.2%
39.0%
31.2%
11.7%

12 month-endpoints
Hospitalized
Hospitalized PPY
Mortality

63.6%
1.1 ± 0.2
13.0%

Hospitalized PPY= Hospitalization per patient per year
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Table 2. Comparing diet components between survivors versus non-survivors and
hospitalized versus not hospitalized
Variable

Energy
(kcal)
Protein(g)
Fat(g)
Sat
Poly
Trans
Total
Fiber(g)
Cereal
fiber (g)
Fruit
(serv.)
Veg.
(serv.)

Survivors

Pvalue*

N=67

Non
survivors
N=10

NotHospitalized
N=49

Hospitalized

1917±400

1615±321

81±16
73.6 ±24.9
23.1±10.7
10.5±7.4
0.9±1.1
17.7± 6.6

Pvalue*

0.026

1937±351

1844± 428

0.332

66±11
76.1± 42.9
20.9±15.8
12.9±5.5
1.0±1.4
16.45± 7.7

0.061
0.778
0.580
0.300
0.810
0.560

80±16
77.13 ±27.5
24.0±10.7
10.7±6.8
0.9±1.1
17.8 ± 6.7

77±16
71.9±27.6
22.1±11.7
10.9±7.4
0.9±1.2
17.4± 6.7

0.441
0.427
0.480
0.901
0.831
0.793

11.5±4.4

7.4±4.4

0.007

11.6±5.0

10.7±4.4

0.424

2.38±0.99

1.5± 0.84

0.009

2.60 ±1.1

2.08 ±0.95

0.029

3.02 ±1.2

2.3±0.94

0.072

3.0± 1.3

2.89 ±1.19

0.721

N=28

*Student T test, statistically significant P<0.05

Table 3. Multivariate Cox regression analysis analyzing Fruit intake for mortality and
hospitalizations
Mortality

Hospitalizations

Variable

Hazard ratio
CI95%

P-value

Hazard ratio
CI95%

P-value

Gender
Age
Diabetic
Fruits (≥2 ser.)

1.23(0.253-5.97)
1.00(0.962-1.05)
2.88(0.587-15.12)
0.24(0.69-0.88)

0.789
0.785
0.192
0.031

0.905(0.481-1.70)
0.99(0.975-1.01)
1.52(0.836-2.79)
0.687(0.352-1.34)

0.757
0.502
0.168
0.272

CI=Confidence interval, statistical significance P<0.05
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Table 4. Multivariable Cox regression analyzing Cereal-fiber intake for mortality and
hospitalizations
Mortality
Variable
Gender
Age
Diabetic
Cereal fiber(≥7 gr.)

Hospitalizations

Hazard ratio
CI 95%
1.96(0.401-9.67)
1.02(0.975-1.074)
1.94(0.386-9.88)
0.187(0.05-0.69)

P-value
0.404
0.347
0.420
0.012

Hazard ratio
CI 95%
0.952(0.507-1.78)
0.995(0.977-1.01)
1.467(0.783-2.74)
0.946(0.512-1.752)

P-value
0.879
0.625
0.231
0.859

CI=Confidence interval, statistical significance P<0.05

Table 5. Comparing AHEI total score and its components between hospitalized versus
not-hospitalized and survivors versus non-survivors
Variable

Survivors

(mean±SD
scores)

AHEI
poly-toSat
transFat
%energy
white-tored meat
cerealfiber
nuts/soy
fruit
vegetable

Non
survivors

N=66
N=10
45.8 ± 9.8 41.84±9.55
7.2 ±2.44

PNotHospitalized Pvalue* Hospitalized
value*
0.229

N=49
45.74±0.60

N=28
45.15 ±9.5

0.820

5.2 ± 3.02

0.062

5.11±3.02

5.7 ± 3.3

0.450

9.49±1.15

9.07±2.50

0.374

9.48 ±1.03

9.41±1.56

0.840

6.3 ±2.9

6.0 ±3.68

0.711

6.30 ±2.98

6.34 ±3.0

0.952

6.02 ± 2.2

4.4± 2.4

0.035

5.94 ±2.2

5.7 ±2.3

0.690

4.89 ±2.2
5.72 ± 2.6
5.64±2.94

4.5 ±3.2
3.4 ±2.4
4.7 ±2.4

0.626
0.010
0.325

4.5± 2.3
6.16± 2.83
5.72 ±2.87

5.0 ±2.3
5.0 ±2.2
5.4 ±2.91

0.339
0.067
0.639

*Student T test, statistically significant P<0.05
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Table 6. Total AHEI score, sub-scores and diet components by comparing participants
grouped into NLR quartilesa
Variable
(mean±SD)

quartile 1
NLR
(£1.75)
N=19

quartile 2
NLR
(1.76-2.6)
N=21

quartile 3
NLR
(2.7-3.9)
N=18

quartile 4
NLR
(≥ 4.0)
N=19

Pvalues*

Diet quality index (scores)
AHEI

49.2±9.6

43.3±7.1

43.3±11.1

poly-to-sat
transFat%enery
white-to-red meat
cereal-fiber
nuts/soy
fruit
vegetable

5.97±3.5
9.7±0.4
6.5±3.0
6.9±2.0
5.2±0.9
6±2.4
6.3±2.7

5.1±2.8
9.2±2.0
7.9±2.5
5.0±2.0
4.4±2.8
5±2.3
4.9±2.6

5.0±3.2
9.3±9.1
6.4±2.9
5.3±2.3
4.3±2.8
5.1±3.1
5.1±2.9

45.5±10.9

0.20

5.7±3.4
9.5±9.2
5.3±3.4
5.8±2.4
5.3±2.2
5.6±2.6
5.6±3.2

0.79
0.62
0.36
0.06
0.50
0.63
0.45

Diet components (servings)
Energy (kcal)
Protein (g)
Fat (g)
Sat.(g)
Poly.(g)
Trans.(g)
Fiber (g)
Cereal-fiber
(g)
Veg.(serv.)
Fruit (serv.)
White/Red
meat (serv.)

Nuts&soy
(serv.)

1902±412
86.6±16.9
64.1±27.1
22.7±9.8
11.8±8.3
0.6±0.6
18.7±7.6
13.4±3.1

1925±451
67.2±17
66.8±20.2
24.3±12.9
10.0±5.3
1.0±1.3
16.5±6.0
9.4±4.2

1779±141
66±16.6
64.4±40.7
23.9±15.3
11.3±6.7
1.1±1.3
17.5±6.7
11.1±5.7

1896±313
82.3±14
69.5±20.3
20.1±5.7
10.3±7.6
0.9±1.6
17.7±6.6
10.2±4.5

0.69
0.64
0.87
0.67
0.85
0.50
0.77
0.04

3.3±1.0
2.4±0.9
3.1±1.2

2.5±1.0
2.0±0.86
3.4±0.9

2.7±1.3
2.1±1.2
2.7±1.2

3.1±1.2
2.4±1.1
2.6±1.5

0.14
0.50
0.18

0.5±0.1

0.4±0.3

0.4±0.2

0.5±0.2

0.50

1 (NLR £ 1.75), quartile 2 (NLR 1.76-2.6), quartile 3 (NLR 2.7-3.9) and quartile 4 (NLR ≥4.0)
*one-way ANOVA test, statistically significant P<0.05

aquartile
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Table 7. Total AHEI score, sub-scores and diet components by comparing participants
grouped in the lowest quartile of inflammation versus the rest
Variable
(mean±SD)

NLR >1.75

NLR £1.75

P-value*

Diet quality index scores
AHEI
poly-to-Sat
transFat%ener
white-to-red
meat
cereal-fiber
nuts/soy
fruit
vegetable

49.2±9.6

44.0±9.6

0.046

5.9±3.5
9.7±0.4
6.5±3.0

5.3±3.1
9.3±1.5
6.2±3.0

0.453
0.264
0.714

6.9±2.0
5.2±0.9
6.0±2.4
6.3±2.7

5.4±2.2
4.7±2.6
5.2±2.7
5.2±2.8

0.014
0.239
0.282
0.144

Diet components (servings)
Energy (kcal)
Protein (g)
Fat (g)
Sat.(g)
Poly.(g)
Trans.(g)
Fiber(g)
Cereal Fiber (g)
Veg(serv)
Fruit(serv)
White/R(serv)
Nut/soy(serv)

1902±412
80.6±16.9
74.1±27.1
22.7±9.8
11.8±8.3
0.6±0.6
18.7±7.6
13.4±3.1
3.3±1.0
2.4±0.9
3.1±1.2
0.5±0.1

1870±402
78.5±15.9
73.7±27.9
22.8±11.9
10.5±6.8
1.0±1.2
17.2±6.4
10.2±4.8
2.8±1.2
2.2±1.0
3.0±1.2
0.4±0.2

NLR= Neutrophil-to-lymphocyte ratio
*Student T test, statistically significant P<0.05
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0.768
0.624
0.955
0.979
0.491
0.064
0.381
0.008
0.110
0.469
0.670
0.372
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CHAPTER VI: SUMMARY OF CONCLUSIONS AND IMPACT ON PRACTICE
This study investigated the impact of neutrophil-to-lymphocyte ratio (NLR),
nutritional status and the diet quantity/quality of 77 hemodialysis (HD) participants on
clinical outcomes, specifically on mortality and hospitalization over one year. The
relationships between diet quantity and nutrition markers, and between diet quality and
inflammation were also explored.
High hospitalization and mortality rates are reported in HD patients;1 these
outcomes have been attributed, in part, to the high prevalence of malnutrition,2
inadequate nutrition intake3 and pro-inflammatory status in this renal condition.4
However, the extent of which each of these factors contributes individually or in
combination to adverse outcomes is a persistent subject of current investigations and
controversies.5
Our findings support the use of neutrophil-to-lymphocyte ratio, an inexpensive
and convenient inflammation marker, as strong predictor of outcomes in hemodialysis
patients, as it was suggested by research in other cohorts of hemodialysis patients and
those with other conditions.6,7 Our results provide preliminary data on the protective
effect that a low neutrophil-to-lymphocyte ratio might have on the risk of hospitalizations
in diabetic patients receiving hemodialysis and provided significant information
regarding other risk factors for hospitalization. We demonstrated a paradoxical
relationship between BMI kg/m2 and the number of hospitalizations; as higher BMI was
associated with lower number of hospitalizations in 12 months. This epidemiological
paradox, in which high BMI is associated with improved survival, is found in patients
with CKD and on those undergoing hemodialysis, and it has been previously reported.8 In
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our cohort, participants with higher BMI had 10% lower risk for hospitalization, which
suggested that, in hemodialysis patients with higher BMI, higher body fat and more years
in dialysis, there is a protective effect on adverse events requiring hospitalizations.
Our results demonstrated an association of nutrition-inflammation status
measured by the malnutrition-inflammation score (MIS) with energy intake, reduced
hospitalization events and mortality risk among hemodialysis patients. Meeting energy
recommendations was shown to have a positive impact on preventing hospitalization and
lowering mortality rates. We also demonstrated that MIS was more sensitive to detect
protein-energy malnutrition and a stronger predictor for disease outcomes than the
Subjective Global Assessment (SGA), a result with implications for practice.
The examination of the average daily intake of energy and protein in our study
cohort revealed that despite advice on improving adequacy of the renal diet from
dietitians, nurses, doctors, and other health professionals, a large proportion of patients
did not meet KDOQI for energy and protein recommendations. Approximately only half
of our participants (53%) met KDOQI energy recommendations, while 55% met protein
recommendations and only 21% met both energy and protein recommendations. These
results are supported by prior reports on dietary energy and protein intakes (DEI and DPI)
in dialysis patients that clearly demonstrated that most dialysis patients do not meet
KDOQI recommendations, which in turn may increase their risk of developing proteinenergy wasting (PEW) and ultimately increase morbidity and mortality rates in this
population.9-13
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In our cohort, patients who died had significantly lower energy intake, ate less
fruit servings per day and consumed lower daily amounts (gm) of cereal fiber. Almost
90% of the participants reported a total fiber intake lower than 25g/day. We demonstrated
that consuming at least two fruit servings per day decreased mortality risk by 75% and
eating at least 7 grams of cereal fiber per day decreased mortality risk by 81%; however,
the impact of the diet quality index (measured by AHEI) was neither significant in
preventing hospitalizations nor mortality.
In our analysis of the relationship between inflammation and diet quality, we
found that in our cohort, participants in the lowest quartile of inflammation had a better
diet quality (greater AHEI scores) and scored higher in the cereal-fiber subcomponent
when compared to the rest of the participants. Based on these findings, we proposed that
hemodialysis patients should be encouraged to use various food sources to meet their
energy and protein requirements as well as to satisfy at least two portions of fruits and
seven grams of cereal fiber per day to prevent cardiovascular mortality.
Our study provided observational evidence for nutrition interventions that aim at
improving nutrition-inflammation status and promote adequate energy, protein and fiber
intakes. Our findings suggest that there are benefits in consuming greater amounts of
cereal-fiber and increasing the overall quality of the diet for modulating inflammation
and decreasing mortality. Considering the socio-economic burden associated with
hemodialysis therapy, efforts must be made to support improving dietary options. In view
of our results, we recommend that the current medical nutrition therapy for HD patients
be modified to afford patients greater food choices by frequently assessing their risks for
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malnutrition and inflammation using simple scoring tools, and by tailoring their diets to
their specific nutritional needs to improve clinical outcomes.
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CHAPTER VII: STRENGTHS AND LIMITATIONS
Our study demonstrated that nutritional assessment, using the well-recognized
Subjective Global Assessment (SGA), the Malnutrition-Inflammation Score (MIS),
and/or the widely available food questionnaires, requires minimal resources to be
performed periodically and systematically, integrating these practices into frequent health
professionals’ clinical routines. These tools provide important information to identify
early patients at risk and to prevent the high hospitalization and mortality rates afflicting
hemodialysis patients. However, developing strategies to effectively tackle proteinenergy wasting (PEW) for improving the clinical outcomes of these patients demands
well- designed intervention studies.
The strengths of this study consisted of capturing and analyzing longitudinal data
and directly assessing dietary intake, instead of indirect measurements such as those
described in most of the nutritional studies conducted in patients with CKD. In addition,
the 24-hour recalls were collected by a registered dietitian, who was responsible for the
routine care of the participants enrolled in this study and familiar with participants’
dietary practices, which ensured high accuracy of the data. The results of this study could
be translated into clinically relevant nutrition interventions for hemodialysis populations.
From a clinical standpoint, our results also increase awareness on the impact of
inflammation, PEW and low diet quality on patient outcomes. Patients and their family
should work closely with their health-care professionals to tailor patients’ diets to
incorporate general renal recommendations based on the patient’s individual needs, but
including a variety of foods within the context of preventing cardiovascular risk. Future
studies should investigate the development of effective programs and innovative
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approaches to implement PEW screening and monitoring, and a systematical assessment
of qualitative and quantitative dietary intakes in hemodialysis patients.
The limitations of this study were a relatively small sample size that was recruited
from one dialysis center, which makes generalization to other HD populations difficult;
however, several minorities were represented in this study as well as a variety of
conditions and dietary needs. A larger sample size might have allowed for calculation of
relevant cut-off points for the novel biomarkers.
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CHAPTER VIII: FUTURE RESEARCH
The results from this study demonstrated that adequate fiber intake could prevent
cardiovascular death and inflammatory processes in patients receiving hemodialysis
therapy. Thus, the relationship of adequate fiber intake with inflammation and
cardiovascular events needs further study, specifically mortality from cardiovascular
disease in this population. In addition, further clinical trials of potential early
interventions are warranted to evaluate the effects of different amounts of fiber intake on
inflammation and to better explain the mechanisms that sustain these effects on mortality.
Cut-off values for inflammation measured by Neutrophil-to-Lymphocyte Ratio (NLR)
and for Malnutrition-Inflammation Score (MIS) are also desperately needed, which will
require much larger sample size than the one analyzed in this study.
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